<SEC-DOCUMENT>0001493152-24-017001.txt : 20240429
<SEC-HEADER>0001493152-24-017001.hdr.sgml : 20240429
<ACCEPTANCE-DATETIME>20240429163025
ACCESSION NUMBER:		0001493152-24-017001
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240429
DATE AS OF CHANGE:		20240429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProPhase Labs, Inc.
		CENTRAL INDEX KEY:			0000868278
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				232577138
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21617
		FILM NUMBER:		24891448

	BUSINESS ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530
		BUSINESS PHONE:		(215) 345-0919

	MAIL ADDRESS:	
		STREET 1:		711 STEWART AVE, SUITE 200
		STREET 2:		GARDEN CITY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			11530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QUIGLEY CORP
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>form10-ka.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:PRPH="http://prophaselabs.com/20231231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_PRPH_prophaselabs.com_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000868278 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000005" name="dei:EntityCentralIndexKey">0000868278</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0043" name="dei:AuditorFirmId">536</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="prph-20231231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000868278</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_907_edei--DocumentType_c20230101__20231231_zDNJfSw7QEz1"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000010" name="dei:DocumentType">10-K/A</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--DocumentAnnualReport_c20230101__20231231_z0Mr3EudxHC3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000011" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended <span id="xdx_900_edei--DocumentPeriodEndDate_c20230101__20231231_zWRefWzrjHl8"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:datemonthdayyearen" id="Fact000012" name="dei:DocumentPeriodEndDate"><span id="xdx_908_edei--CurrentFiscalYearEndDate_c20230101__20231231_zKYXTQ5bh6z8"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:datemonthdayen" id="Fact000013" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric></span>, <span id="xdx_903_edei--DocumentFiscalYearFocus_c20230101__20231231_zdnPx1aRgVVe"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000014" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric></span></ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--DocumentTransitionReport_c20230101__20231231_zCLRQAJAMLth"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000015" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
    REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from ______ to ______</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number <span style="text-decoration: underline"><span id="xdx_903_edei--EntityFileNumber_c20230101__20231231_zxOaM4CJX6x9"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000016" name="dei:EntityFileNumber">000-21617</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20230101__20231231_z4Whc96vFD89"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000017" name="dei:EntityRegistrantName">ProPhase
Labs, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20230101__20231231_zfZIhyHJ8zKa"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20230101__20231231_z07CqtL0Pms1"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000019" name="dei:EntityTaxIdentificationNumber">23-2577138</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <br/>
of incorporation or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer<br/>
 Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20230101__20231231_z5wROVeqJK6h"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000020" name="dei:EntityAddressAddressLine1">711
    Stewart Avenue</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20230101__20231231_zvrMtFVXI0p9"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000021" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20230101__20231231_zfIhKVQi8W82"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000022" name="dei:EntityAddressCityOrTown">Garden
    City</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20230101__20231231_z1hQI3vZ1G5c"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:stateprovnameen" id="Fact000023" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressPostalZipCode_c20230101__20231231_zHDKlk9H3jP3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000024" name="dei:EntityAddressPostalZipCode">11530</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--CityAreaCode_c20230101__20231231_zJcQfLongvq2"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000025" name="dei:CityAreaCode">(215)</ix:nonNumeric></span>
<span id="xdx_90A_edei--LocalPhoneNumber_c20230101__20231231_zus3xRNBCNX6"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000026" name="dei:LocalPhoneNumber">345-0919</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--Security12bTitle_c20230101__20231231_z9DM258r6zsf"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, $0.0005 par value per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--TradingSymbol_c20230101__20231231_zs7xu7yan7Bi"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000028" name="dei:TradingSymbol">PRPH</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--SecurityExchangeName_c20230101__20231231_zQrBDfVNwEz3"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span>
    Capital Market</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Act: None</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_901_edei--EntityWellKnownSeasonedIssuer_c20230101__20231231_zWmdTQRCtYdc"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000030" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_902_edei--EntityVoluntaryFilers_c20230101__20231231_zwCJff6yVJ49"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000031" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_90C_edei--EntityCurrentReportingStatus_c20230101__20231231_zigsZMEK1Fyf"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000032" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>  &#9746; No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;229.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was
required to submit such files). <span id="xdx_90D_edei--EntityInteractiveDataCurrent_c20230101__20231231_zdZP3ziC8RM7"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000033" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> &#9746;  No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See definition of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller
reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 35%; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityFilerCategory_c20230101__20231231_zOvYHvmF5kXl"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt-sec:entityfilercategoryen" id="Fact000034" name="dei:EntityFilerCategory">Accelerated
    filer</ix:nonNumeric></span> </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntitySmallBusiness_c20230101__20231231_zZar9sZmuJ4h"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000035" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20230101__20231231_zkJBl19PNbBj"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000036" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <span id="xdx_905_edei--IcfrAuditorAttestationFlag_c20230101__20231231_zxnaE1SOmayk"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleantrue" id="Fact000037" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_906_edei--DocumentFinStmtErrorCorrectionFlag_c20230101__20231231_z8NupWNNMB2b"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000038" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  &#9744; No <span id="xdx_90D_edei--EntityShellCompany_dbF_c20230101__20231231_zhdj7lsx4OKh"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" format="ixt:booleanfalse" id="Fact000039" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the registrant&#8217;s voting and non-voting common stock held by non-affiliates was $<span id="xdx_900_edei--EntityPublicFloat_iI_c20230630_zoR7xzU7ICSl"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2023-06-30" id="Fact000040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,240,301</ix:nonFraction></span> as of June
30, 2023, based on the closing price of the common stock on The Nasdaq Capital Market on such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
of March 15, 2024, there were <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_pid_c20240315_znUgaVo2Qpla"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2024-03-15" id="Fact000041" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,045,209</ix:nonFraction></span> shares outstanding of the registrant&#8217;s common stock, par value $0.0005 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DOCUMENTS
INCORPORATED BY REFERENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--DocumentsIncorporatedByReferenceTextBlock_c20230101__20231231_zJWg3eKJnXEe"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000042" name="dei:DocumentsIncorporatedByReferenceTextBlock">None</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditor
Firm PCAOB ID: <span id="xdx_903_edei--AuditorFirmId_c20230101__20231231_zFMTnKGTFUfg"><span style="-sec-ix-hidden: xdx2ixbrl0043">00536</span></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditor
    Name: <span id="xdx_90B_edei--AuditorName_c20230101__20231231_zC2UVodBoKT4"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000044" name="dei:AuditorName">Morison Cogen LLP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Auditor
    Location: <span id="xdx_904_edei--AuditorLocation_c20230101__20231231_zbi26Xowql2i"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000045" name="dei:AuditorLocation">Blue Bell, Pennsylvania</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXPLANATORY
NOTE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--AmendmentDescription_c20230101__20231231_zgBEtTWUmUE4"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000046" name="dei:AmendmentDescription">ProPhase
Labs, Inc.. (the &#8220;Company,&#8221; &#8220;ProPhase,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is filing this
Amendment No. 1 on Form 10-K/A (this &#8220;Amendment&#8221;) to amend our Annual Report on Form 10-K for the year ended December 31,
2023, originally filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 29, 2024 (the &#8220;Original 10-K&#8221;),
to (i) include the information required by Items 10 through 14 of Part III of Form 10-K and (ii) amend Item 15 of Part IV of the Original
10-K to update the exhibit list. The information required by Items 10 through 14 of Part III of Form 10-K was previously omitted from
the Original 10-K in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to
be incorporated in the Form 10-K by reference from our definitive proxy statement if such statement is filed no later than 120 days after
our fiscal year-end. We are filing this Amendment to include Part III information in our Form 10-K because a definitive proxy statement
containing such information will not be filed by us within 120 days after the end of the fiscal year covered by the Form 10-K.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), Part III, Items 10
through 14 of the Original 10-K are hereby amended and restated in their entirety. Additionally, in accordance with Rules 12b-15 and
13a-14 under the Exchange Act, we have amended Part IV, Item 15 to include currently dated certifications pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002. Since no new financial statements have been included in this Amendment, and this Amendment does not contain
or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted.
Similarly, since no financial statements have been included in this Amendment, certifications pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 have been omitted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the changes to Part III and Item 15 of Part IV, including the filing of related certifications added to the exhibit list in Part
IV, this Amendment makes no changes to the Original 10-K. This Amendment does not reflect events occurring after the filing of the Original
10-K or modify disclosures affected by subsequent events. Terms used but not otherwise defined in this Amendment have such meaning as
ascribed to them in the Original 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc_001"></span>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_001">PART III</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_002">Directors, Executive Officers and Corporate Governance</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_003">Executive Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_004">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_005">Certain Relationships and Related Transactions, and Director Independence</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_006">Principal Accountant Fees and Services</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_007">PART IV</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_008">Exhibits and Financial Statement Schedules</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#b_009">Signatures</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_001"></span>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_002"></span>Item
    10.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors,
    Executive Officers and Corporate Governance</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table and the paragraphs following the table set forth information regarding the current ages, positions, and business experience
of our directors as of April 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 42%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 24%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial
    Year in Office</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2009</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Barr</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louis
    Gleckel, MD</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">68</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2009</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren
    Hirsch</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TED
KARKUS</b> has been the Chairman of the Board and the Chief Executive Officer of the Company since June 2009. Mr. Karkus was instrumental
in assisting the turnaround of ID Biomedical, an influenza vaccine manufacturer, which in 2005 was sold to GlaxoSmithKline plc for over
$1.4 billion. Mr. Karkus has twenty-five years of experience in securities and capital markets including two years with Fahnestock &amp;
Co. Inc., a full-service brokerage firm, where he was Senior Vice President, Director of Institutional Equities, and four years at S.G.
Warburg, an investment bank, where he was an institutional equity salesman and developed a large network of institutional investors.
Mr. Karkus graduated with an MBA from Columbia University Graduate School of Business in 1984 where he received Beta Gamma Sigma honors.
He graduated Magna Cum Laude from Tufts University in 1981.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Karkus brings extensive financial structuring as well as operational and marketing strategy experience to our Board, including successful
restructuring and turn-around scenarios in the pharmaceutical industry. Among his accomplishments, in 2010/2011 he led the restructuring
and streamlining of our operations, which resulted in improved sales and margins of our Cold-EEZE brand, and in 2017 succeeded in selling
the Cold-EEZE brand for $50 million to Mylan, a multibillion-dollar pharmaceutical company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JASON
M. BARR</b> has been a member of our Board since June 2015 and currently serves as a member of the Audit Committee and Nominating and
Corporate Governance Committee and as chairman of the Compensation Committee. Since February 2022, Mr. Barr has served in various roles,
and currently as the SVP, Senior Corporate Counsel &amp; Assistant Secretary for Sportradar Group AG (Nasdaq: SRAD), the leading global
sports technology company. From September 2020 to February 2022, he was General Counsel and Secretary of Ithaca Holdings, LLC, a Los
Angeles based entertainment and music company. From February 2018 to September 2020, Mr. Barr held various senior roles with TRU Kids
Inc. and its predecessor, Toys R Us, Inc., the global toys and baby products retailer. He previously held senior roles, including Chief
Legal Officer, SVP and Secretary of LiveStyle, Inc. (f/k/a SFX Entertainment, Inc.), a global live events and media company, from August
2013 to October 2017. Prior to his employment with LiveStyle, Mr. Barr was a corporate and securities attorney at Reed Smith LLP in New
York City from 2007 to 2013. He served from December 2015 to June 2018 as a member of the board of directors of Susquehanna Polling &amp;
Research, Inc., a public opinion polling company with a national reputation for expert polling for corporate, consumer and political
clients. Mr. Barr graduated from Suffolk University Law School in 2007 and received his bachelor&#8217;s degree from Dickinson College
in 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Barr brings to our Board knowledge and expertise with corporate finance, mergers and acquisitions, commercial law, brand development,
risk management, and regulatory matters including reporting compliance with the Securities and Exchange Commission (the &#8220;SEC&#8221;),
NASDAQ and corporate governance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LOUIS
GLECKEL, MD,</b> has been a member of our Board since June 2009 and currently serves as a member of the Audit Committee and Compensation
Committee and as chairman of the Nominating and Corporate Governance Committee. In 1997, Dr. Gleckel co-founded ProHealth Care Associates,
a comprehensive state of the art multi-specialty physician group practice with offices in Long Island and Bronx, New York. At ProHealth,
he is the Division Chief of Cardiology and Internal Medicine specializing in Preventative Cardiology, Metabolic Syndrome and Internal
Medicine with particular emphasis on high-risk patients with complications from diabetes and heart disease. He was named to New York
Magazine&#8217;s Best Doctors list for three years, New York Metro Area Best Doctors list for 14 years and the 2008 Nassau County Best
Doctors list. For over ten years Dr. Gleckel has been a team physician for the New York Jets and New York Islanders as well as for the
tennis players at the US Open. Dr. Gleckel also served as Chairman of the Board of Invicta Corporation, a development stage company that
designed, manufactured and marketed photochromic eyeglass lenses, for approximately four years until his resignation in February 2005.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
Gleckel brings to the Board extensive knowledge of the medical, pharmaceutical and related industries as a distinguished doctor, as well
as experience in successful business development and board service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARREN
HIRSCH</b> has been a member of our Board since 2019 and currently serves as a member of the Compensation Committee and Nominating and
Corporate Governance Committee and as chairman of the Audit Committee. Mr. Hirsch has over 35 years of experience as a Certified Public
Accountant. Mr. Hirsch owns and operates Hirsch and Hirsch CPA PLLC, which offers a full range of accounting, tax and small business
consulting services. From 2000 to May 2019, Mr. Hirsch served as a registered representative of Royal Alliance, a national financial
advisory firm. Mr. Hirsch graduated with a bachelor&#8217;s degree in accounting from Hofstra University in 1980.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Hirsch has extensive knowledge and background related to accounting and financial reporting rules and regulations as well as the evaluation
of financial results, internal controls and business processes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors Leadership Structure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
governance structure combines the roles of principal executive officer and Board Chairman. Mr. Karkus has served as both Chairman and
Chief Executive Officer of the Company since June 2009. The Board believes there are important advantages to Mr. Karkus serving in both
roles at this time, but may revisit this structure at its discretion in the future. Mr. Karkus is the director most familiar with our
Company&#8217;s business and industry and is best situated to propose the Board&#8217;s agendas and lead Board discussions on important
matters. Mr. Karkus provides a strong link between management and the Board, which promotes clear communication and enhances strategic
planning and implementation of corporate strategies. Another advantage is the clarity of leadership provided by one person representing
the Company to employees, stockholders and other stakeholders. The Board has not named a lead independent director.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Oversight</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is actively involved in oversight of risks that could affect us. This oversight is conducted primarily by our full Board, which
has responsibility for general oversight of risks, and through delegation to the Audit Committee. The Board satisfies this responsibility
through full reports by each committee chair regarding the committee&#8217;s considerations and actions, as well as through regular reports
directly from officers responsible for oversight of particular risks within our Company. The Board believes that full and open communication
between management and the Board is essential for effective risk management and oversight.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our Board monitors our exposure to a variety of risks through our Audit Committee. Our Audit Committee Charter gives the Audit
Committee responsibilities and duties that include discussing with management and the independent registered public accounting firm,
our major financial risk exposures and the steps management has taken to monitor and control such exposures, including our risk assessment
and risk management policies, notably cybersecurity. Pursuant to the Audit Committee Charter, such discussions should also include our
exposure to counterparties or other institutions that we believe are at risk of significant financial distress.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has established three committees: the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance
Committee (the &#8220;Nominating Committee&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current members of the Audit Committee are Jason Barr, Louis Gleckel and Warren Hirsch. Mr. Hirsch serves as Chairman of the Audit Committee.
The Audit Committee has been established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the
&#8220;Exchange Act&#8221;). The Board has determined that each of Messrs. Barr and Hirsch and Dr. Gleckel meets the independence requirements
of the Nasdaq listing standards for audit committee members. Additionally, our Board has affirmatively determined that each of Messrs.
Barr and Hirsch and Dr. Gleckel is &#8220;independent&#8221; as defined by the applicable SEC rules regarding audit committee independence.
Our Board has determined that Mr. Hirsch qualifies as an &#8220;audit committee financial expert&#8221; as defined by the rules of the
SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee reviews, analyzes and makes recommendations to the Board with respect to the Company&#8217;s accounting policies, internal
controls and financial statements, consults with the Company&#8217;s independent registered public accountants, and reviews filings containing
financial information of the Company to be made with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee met 5 times during 2023. The Audit Committee operates under a written charter adopted by the Board, which is available
on our website at <i>www.ProPhaseLabs.com </i>under &#8220;<i>Investor Relations &#8212;Governance&#8212; Governance Documents</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
current members of the Compensation Committee are Jason Barr, Louis Gleckel and Warren Hirsch. Mr. Barr serves as Chairman of the Compensation
Committee. The Board has determined that each of Messrs. Barr and Hirsch and Dr. Gleckel meets the independence requirements of the Nasdaq
listing standards for compensation committee members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee reviews and approves the salary and all other compensation of officers of the Company, including non-cash benefits,
incentive-based awards and equity-based awards. The Compensation Committee also administers the Company&#8217;s equity incentive plans.
The Compensation Committee may form subcommittees and delegate authority to such subcommittees or to one or more of its members when
appropriate. The Compensation Committee has the authority to engage consultants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee met 3 times during 2023. The Compensation Committee operates under a written charter adopted by the Board, which
is available on our website at <i>www.ProPhaseLabs.com</i> under &#8220;<i>Investor Relations &#8212;Governance&#8212; Governance Documents</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nominating
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of the Nominating Committee are Jason Barr, Louis Gleckel and Warren Hirsch. Dr. Gleckel serves as Chairman of the Nominating
Committee. The Board has determined each of Messrs. Barr and Hirsch and Dr. Gleckel meets the independence requirements of the Nasdaq
listing standards for nominating committee members.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee is responsible for developing and recommending criteria for selecting new directors and oversees evaluations of
the Board and committees of the Board. The Nominating Committee has the responsibility to oversee the Company&#8217;s Corporate Governance
Guidelines and propose changes to such guidelines from time to time as may be appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee met 1 time during 2023. The Nominating Committee operates under a written charter adopted by the Board, which is
available on our website at <i>www.ProPhaseLabs.com</i> under &#8220;<i>Investor Relations &#8212;Governance&#8212; Governance Documents</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meetings
of the Board of Directors in 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended December 31, 2023, there were 9 meetings of the Board. Each of the directors attended, in person or by telephone,
more than 75% of the meetings of the Board and the committees on which he served.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
independent members of the Board met in executive session 5 times during 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
director is expected to make reasonable efforts to attend Board meetings, meetings of committees of which such director is a member and
annual meetings of stockholders. All four of the directors attended the 2023 Annual Meeting of Stockholders either in person or by video
conference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Nominations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
selecting candidates for appointment or re-election to the Board, the Nominating Committee considers the following criteria:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personal
    and professional ethics and integrity, including a reputation for integrity and honesty in the business community.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experience
    as an executive officer of companies or as a senior leader of complex organizations, including scientific, government, educational,
    or large not-for-profit organizations. The Nominating Committee may also seek directors who are widely recognized as leaders in the
    fields of medicine or the biological sciences and manufacturing or business generally, including those who have received awards and
    honors in their field.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    knowledge, including an understanding of finance, accounting, the financial reporting process, and company measures for operating
    and strategic performance.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Possess
    the fundamental qualities of intelligence, perceptiveness, fairness, and responsibility.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ability
    to critically and independently evaluate business issues, contributing a diverse perspectives or viewpoints, and making practical
    and mature judgments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    genuine interest in the Company, and the ability to spend the time required to make substantial contributions as a director.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    conflict of interest or legal impediment that would interfere with the duty of loyalty to the Company and its stockholders.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    ownership of common stock of the Company, or a willingness to acquire shares of common stock, to further align the interests of non-employee
    directors with the interests of the Company&#8217;s stockholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors
should have varied educational and professional experiences and backgrounds that, collectively, provide meaningful guidance and counsel
to management. Diversity of background, including gender, race, ethnic or national origin, age, and experience in business, government,
education, international experience and other areas relevant to the Company&#8217;s business are factors considered in the selection
process. As a company, we are committed to creating and sustaining a culture of inclusion and fairness. In addition, the Nominating Committee
reviews the qualifications of the directors to be appointed to serve as members of the Audit Committee to ensure that they meet the financial
literacy and sophistication requirements under applicable Nasdaq rules and that at least one of them qualifies as an &#8220;audit committee
financial expert&#8221; under the applicable SEC rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is information concerning the gender and demographic background of each of our current directors, as self-identified and
reported by each director. This information is being provided in accordance with Nasdaq&#8217;s board diversity rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Board Diversity Matrix (As of April 29, 2024)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Total Number of Directors:</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1.5pt solid; text-align: center">4</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Female</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Male</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Non-Binary</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center">Did Not <br/>Disclose Gender</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Part I: Gender Identity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%">Directors</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: center">0</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: center">3</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: center">0</td><td style="width: 2%">&#160;</td>
    <td style="width: 14%; text-align: center">1</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Part II: Demographic Background</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">African American or Black</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Alaskan Native or Native American</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Asian</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Hispanic or Latinx</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Native Hawaiian or Pacific Islander</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>White</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">3</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Two or More Races or Ethnicities</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td><td>&#160;</td>
    <td style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>LGBTQ+</td><td>&#160;</td>
    <td colspan="7" style="text-align: center">0</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Did Not Disclose Demographic Background</td><td>&#160;</td>
    <td colspan="7" style="text-align: center">1</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee and the Board have historically taken an approach that neither favors nor disfavors any particular color, race,
creed, or gender. The Board evaluates all candidates equally across all relevant factors and seeks members whose background, qualifications
and skills will assist the Company in accomplishing its goals. The Board has engaged with stockholders on the topic of diversity. The
Board and the Nominating Committee are committed to identifying and engaging a diverse field of director candidates when considering
Board composition in the future. However, the Company does not currently plan on increasing the size of the Board and is not currently
in the process of searching for new director candidates. When a vacancy on the Board arises, the Nominating Committee will actively identify
qualified diverse candidates to include in the pool from which Board nominees are selected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Director
Nominations from Stockholders</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating Committee will consider written proposals from stockholders for nominees for director. Any such nominations must be submitted
to the Nominating Committee in accordance with Article 2.15 of the Company&#8217;s Bylaws to the Secretary at the Company&#8217;s principal
executive office. For a stockholder to make any nomination of a person or persons for election to the Board at an annual meeting, the
stockholder must provide timely notice and certain information about the stockholder and the nominee. to be timely, a stockholder&#8217;s
notice must be delivered to, or mailed and received at, the principal executive office of the company not less than 90 days nor more
than 120 days prior to the one-year anniversary of the preceding year&#8217;s annual meeting; provided, however, that if the date of
the annual meeting is more than 30 days before or more than 60 days after such anniversary date, notice by the stockholder to be timely
must be so delivered, or mailed and received, not later than the 90th day prior to such annual meeting, or, if such meeting is announced
later than the 90th day prior to the date of such meeting, not later than the 10<sup>th</sup> day following the day on which public disclosure
(as defined in article 2.15 of the bylaws) of the date of such annual meeting was first made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
must be provided for (i) the stockholder providing the notice of the nomination proposed to be made at the meeting, (ii) the beneficial
owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made, (iii)
any affiliate or associate of such stockholder or beneficial owner, and (iv) any other person with whom such stockholder or such beneficial
owner (or any of their respective affiliates or associates) is acting in concert. Each such person must provide (A) the name and address
of such person (including, if applicable, the name and address that appear on the Company&#8217;s books and records); and (B) the class
or series and number of shares of the Company that are, directly or indirectly, owned of record or beneficially owned (within the meaning
of Rule 13d-3 under the Exchange Act), by such person, except that such person will in all events be deemed to beneficially own any shares
of any class or series of the Company as to which such person has a right to acquire beneficial ownership at any time in the future.
In addition, each person must provide information relating to their derivative and short positions in the Company&#8217;s securities,
as set out in the Company&#8217;s Bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, each director nominee must provide the same information, as well as all information relating to such proposed nominee that
is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for
election of directors in a contested election pursuant to Section 14(a) under the Exchange Act (including such proposed nominee&#8217;s
written consent to being named in the proxy statement as a nominee and to serving as a director if elected), a description of all direct
and indirect compensation and other material monetary agreements, arrangements and understandings during the past three years, and any
other material relationships, between or among any nominating stockholder, on the one hand, and each proposed nominee, his or her respective
affiliates and associates and any other persons with whom such proposed nominee (or any of his or her respective affiliates and associates)
is acting in concert, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant
to Item 404 under Regulation S-K if such nominating stockholder were the &#8220;registrant&#8221; for purposes of such rule and the proposed
nominee were a director or executive officer of such registrant, and a completed and signed questionnaire, provided by the Company&#8217;s
Secretary relating to any voting commitments. The Company may require any proposed nominee to furnish such other information (A) as may
reasonably be required by the Company to determine the eligibility of such proposed nominee to serve as an independent director of the
Company or (B) that could be material to a reasonable stockholder&#8217;s understanding of the independence or lack of independence of
such proposed nominee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governance
Policies and Procedures</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Code
of Conduct</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a code of conduct that applies to all members of our Board and all employees of the Company, including our principal executive
officer, principal financial officer and other senior financial officers. The Code of Conduct is available on our website at <i>www.ProPhaseLabs.com
</i>under &#8220;<i>Investor Relations &#8212;Governance&#8212; Governance Documents</i>.&#8221; We have not granted any waivers under
this policy to any of our directors or executive officers. <span style="background-color: white">In the event that we amend or waive
certain provisions of our code of ethics applicable to our principal executive officer, principal financial officer or principal accounting
officer that requires disclosure under applicable SEC rules, we intend to disclose the same on our website.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Corporate
Governance Guidelines</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board has adopted Corporate Governance Guidelines to promote effective governance of the Company. The Corporate Governance Guidelines
are available on our website at <i>www.ProPhaseLabs.com</i> under &#8220;<i>Investor Relations &#8212;Governance&#8212; Governance Documents</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Whistleblower
Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has established a whistleblower policy by which confidential complaints may be raised anonymously within the Company. Employees
that wish to submit complaints confidentially should submit an anonymous written complaint directly to the Compliance Officer (as described
in the policy). Complaints submitted through this confidential process that involve the Company&#8217;s accounting, auditing, and internal
auditing controls and disclosure practices will be presented to the Audit Committee. The policy is available on our website at <i>www.ProPhaseLabs.com
</i>under &#8220;<i>Investor Relations &#8212;Governance&#8212; Governance Documents</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insider
Trading Policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains an insider trading policy that provides that the Company&#8217;s personnel may not buy, sell or engage in other transactions
in the Company&#8217;s stock while aware of material non-public information and that restricts trading in Company securities for a limited
group of Company employees (including executive officers and directors) to defined window periods that follow our quarterly earnings
releases. The policy is available on our website at <i>www.ProPhaseLabs.com</i> under &#8220;<i>Investor Relations &#8212;Governance&#8212;
Governance Documents</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s Insider Trading Policy also provides that directors, officers and employees should not engage in any of the following
activities with respect to the securities of the Company: (i) trading in securities on a short-term basis by directors and officers (any
security of the Company purchased by an officer or director must be held for a minimum of six months prior to sale, unless the security
is subject to forced sale, including as a result of a merger or acquisition involving the Company; (ii) purchase on margin; (iii) short
sales; or (iv) buying or selling puts, calls or options to purchase or sell any of the Company&#8217;s securities, other than options
granted by the Company or bona fide pledges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Procedures
for Contacting Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted a procedure by which stockholders may send communications to one or more members of the Board by writing to such
director(s) or to the whole Board, care of the Corporate Secretary, ProPhase Labs, Inc., 711 Stewart Avenue, Suite 200, Garden City,
New York 11530. The mailing envelope should contain a clear notation indicating that the enclosed letter is a &#8220;Board Communication&#8221;
or &#8220;Director Communication.&#8221; All such letters must clearly state whether the intended recipients are all members of the Board
or just certain specified individual directors. The Secretary will make copies of all such letters and circulate them to the appropriate
director or directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table and the paragraphs following the table set forth information regarding the current ages, positions, and business experience
of the current executive officers of the Company as of April 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Position</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Age</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jed
    A. Latkin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;<i>Our Directors</i>&#8221; for Mr. Karkus&#8217;s biography.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>JED
A. LATKIN</b> has served the Company&#8217;s Chief Operating Officer since January 1, 2024. In his capacity as Chief Operating Officer,
Mr. Latkin also serves as the Company&#8217;s principal financial officer and principal accounting officer. Previously, Mr. Latkin served
as a director and Chief Executive Officer of Navidea Biopharmaceuticals, Inc. (&#8220;Navidea&#8221;) from October 2018 until October
2021 and as Chief Operating Officer and Chief Financial Officer of Navidea from May 2017 to October 2018. Mr. Latkin also served as Interim
Chief Operating Officer of Navidea from April 2016 to April 2017. Mr. Latkin has more than twenty eight years of experience in the financial
industry supporting many investments in major markets. including biotechnology and pharmaceuticals. He most recently was employed by
Nagel Avenue Capital, LLC since 2010, and in that capacity he provided contracted services as a Turnaround Specialist for numerous companies
and asset management firms. Mr. Latkin was responsible for a large diversified portfolio of asset-based investments in varying industries,
including product manufacturing, agriculture, energy, and healthcare. In connection with this role, he served as Chief Executive Officer
of End of Life Petroleum Holdings, LLC and Black Elk Energy, LLC, Chief Financial Officer of Viper Powersports, Inc. and West Ventures,
LLC, and Portfolio Manager of Precious Capital, LLC. Mr. Latkin previously served on the Board of Directors for Navidea from October
2018 until October 2021, CORAR from October 2018 until October 2021, Viper Powersports, Inc. from 2012 to 2013, and the Renewable Fuels
Association and Buffalo Lake Advanced Biofuels. Mr. Latkin worked for over ten years in Investment Banking at Citigroup, Morgan Stanley,
and Fleet Boston Robertson Stephens. He also spent five years as a Co-Portfolio Manager for ING Investment Management. Mr. Latkin earned
a B.A. from Rutgers University and a M.B.A. from Columbia Business School.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Involvement
in Certain Legal Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the best of our knowledge, none of our directors or executive officers has been involved in any material legal proceeding during the
past ten years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Family
Relationships</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among any of our directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_003"></span>Item
    11.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
    Compensation</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary
Compensation Table (2023 and 2022)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary compensation table sets forth the total compensation paid or accrued for the years ended December 31, 2023 and 2022
to our Chief Executive Officer, our former Chief Accounting Officer and our former Chief Financial Officers. We refer to these officers
as our &#8220;named executive officers&#8221; for 2023 and 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Principal</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(2)</sup></b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Ted Karkus</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">675,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">200,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">2,465,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">27,200</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,367,200</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left">Chief Executive Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">675,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">902,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Morse<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">275,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,890</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">246,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">541,390</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: justify">Former Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica Brady<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">210,680</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: left">Former Chief Accounting Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">200,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,680</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">210,680</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill White<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; font-style: italic; text-align: justify">Former Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">147,644</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,640,000</td><td style="text-align: left"><sup>(6)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,867</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,889,511</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            Mr. Karkus, the amount reported for 2023 consists of a $200,000 discretionary bonus awarded
                                            to Mr. Karkus in March 2023 for his 2022 contributions to the Company and for 2022 consists
                                            of a $200,000 discretionary bonus awarded to Mr. Karkus in March 2022 for his 2021 contributions
                                            to the Company.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Mr. Morse, the amount reported for 2023 consists of a $19,890 discretionary bonus awarded to Mr. Morse in March 2023 for his 2022
    contributions to the Company.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                            Mr. Karkus, the amounts reported for 2023 and 2022 consists of a $15,000 vehicle allowance
                                            and a $12,200 matching contribution to the Company&#8217;s 401(k) defined contribution plan.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Ms. Brady, the amounts reported for 2023 and 2022 consists of a $5,000 vehicle allowance and a $5,680 matching contribution in the
    Company&#8217;s 401(k) defined contribution plan.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    Mr. White, the amount reported for 2022 consists of $1,867 matching contribution in the Company&#8217;s 401(k) defined contribution
    plan, a $10,000 separation payment upon his resignation and $90,000 in consulting fees for consulting services provided to the Company
    following his resignation through December 31, 2023 (See &#8220;<i>White Separation Agreement and Release</i>&#8221; below for additional
    details regarding the payments received by Mr. White in connection with his resignation).</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Morse resigned as Chief Financial Officer and resumed his role as Controller, effective January 1, 2024. Although Mr. Morse continues
    to work for the Company, he is no longer the principal financial officer and principal accounting officer of the Company. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
    Brady resigned as Chief Accounting Officer effective January 13, 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    White resigned as Chief Financial Officer effective October 4, 2022.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    the aggregate grant date fair value of the inducement stock option award granted to Mr. White on May 9, 2022, determined in accordance
    with FASB ASC Topic 718. For a discussion of the assumptions and methodologies used to value the option award granted, see Note 7
    &#8220;Stockholders&#8217; Equity&#8221; to the financial statements included in our 2023 Annual Report. This award was subsequently
    forfeited on October 4, 2022 in connection with Mr. White&#8217;s resignation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
Philosophy</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee believes that the most effective compensation program should:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">attract
    and retain talented executives who will lead us through the challenges that we may face and put us in a position to grow and succeed;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">motivate
    our executives to achieve short-term, medium-term and long-term financial and strategic goals;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reward
    our executives for the achievement of individual and corporate objectives; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">align
    the interests of management with those of our stockholders by providing incentives for superior performance that improves stockholder
    value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no pre-established policy or target for the allocation between either cash and non-cash or short-term, medium-term and long-term incentive
compensation. This approach provides our Compensation Committee the ability to evaluate the compensation package from year to year with
the flexibility to configure allocations and amounts in a manner that aligns closely with stockholder interests. The Compensation Committee
considers our corporate performance, individual performance, and the economic environment in general and in our industry when it makes
compensation decisions. The Compensation Committee uses these factors, in conjunction with its overall compensation philosophy, when
it determines compensation to be awarded to our executive officers during a fiscal year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we do not have any policy for the proportion of compensation that should be allocated as cash or non-cash, or short or long-term, we
have historically paid our executive officers a greater percentage of their total compensation as base salary. This is due to market
factors in our industry and the specific situations facing our Company. It is important for us to retain the services of our talented
and experienced executive team through market fluctuations. To do so, we believe that it is important to provide a certain amount of
fixed compensation that will give our executive officers some assurance as to the level of compensation they will earn.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have utilized annual bonus awards to reward results or extraordinary efforts, which motivates our executive officers to produce positive
short-term results. We grant stock options and other stock-based awards, which align the long-term interests of our executive officers
to the interests of our stockholders by making our executive officers stakeholders in the Company and tying their long-term interests
to our success.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee does not specifically benchmark the compensation of our executives to the pay of other executives in companies
of similar size in our industry, given the unique challenges that are faced by other companies of our size in our industry. However,
we have historically compared the level of our executives&#8217; compensation against the compensation of other companies in our industry
in general, and believe that the level of compensation our executives receive is within the range of compensation paid to other executives
in our industry. We use these compensation checks to ensure that our executives are being appropriately rewarded and to discourage their
departure to any competitor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding
most compensation matters, the Chief Executive Officer&#8217;s responsibility is to provide recommendations to the Compensation Committee
based on an analysis of market standards and trends and an evaluation of the contribution of each executive officer to the Company&#8217;s
performance. Our Compensation Committee considers, but retains the right to accept, reject or modify such recommendations. Neither the
Chief Executive Officer nor any other member of management is present during executive sessions of the Compensation Committee. Moreover,
the Chief Executive Officer is not present when decisions with respect to his compensation are made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022
Advisory Stockholder Vote on Executive Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 19, 2022, at our 2022 Annual Meeting of Stockholders, our stockholders overwhelmingly approved, on a non-binding advisory basis,
the compensation of the Company&#8217;s named executive officers, including the Company&#8217;s compensation practices and principles
and their implementation, as discussed and disclosed in the compensation tables and related narrative disclosure (the &#8220;Say on Pay
Vote&#8221;) contained in our 2022 Proxy Statement. The Compensation Committee appreciates and values the views of our stockholders.
In light of the strong level of support of the overall pay practices, and of the general effectiveness of our long standing compensation
policies, the Board and the Compensation Committee have not made any specific changes to our executive compensation program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the 2019 Annual Meeting of Stockholders on May 22, 2019, our stockholders expressed a preference that our Say on Pay Vote occur every
three years. In accordance with the results of this vote, the Board determined to implement a Say on Pay Vote every three years. As such,
our Board will provide a Say on Pay Vote among the matters to be considered at the Company&#8217;s 2025 Annual Meeting of stockholders.
The next required vote on the frequency of Say on Pay Votes, which is required to be held at least every six years, will be held at our
2025 Annual Meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Elements
of Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to variation where appropriate, the elements of compensation to our named executive officers include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">base
    salary, which is determined on an annual basis and is generally set forth in employment agreements with our executives;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">annual
    cash incentive compensation, which is awarded by our Compensation Committee on a discretionary basis, determined based on the Company
    and individual performance in the applicable fiscal year; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">long-term
    incentive compensation in the form of options and other stock-based awards.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Base
Salary and Annual Bonus</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Base
salaries are an integral component of our total compensation program, and setting base salaries at competitive levels helps us to attract
and retain senior executives. Base salary is the only fixed component of compensation for our executives. The base salaries for our named
executive officers were determined based on the Compensation Committee&#8217;s evaluation of the competitive marketplace, the salaries
of our other executives, and the scope of each named executive officer&#8217;s responsibilities. The base salaries of our named executive
officers were set at the level deemed necessary to secure their employment for an extended period and to appropriately reward them for
the multiple roles they played for our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
annual bonus opportunity is intended to incentivize the achievement of our short-term goals. On an annual basis, generally in mid-December,
our Compensation Committee assesses the individual performance of each of our executive officers and the performance of the Company and
determines the appropriate annual bonus award, if any, for our executive officers. We do not use pre-established targets for the annual
bonus award because market factors that affect our Company&#8217;s performance are unpredictable, and thus it would be difficult to set
goals at the beginning of the fiscal year that would appropriately motivate our executive officers throughout the year. By basing the
annual incentive on assessments made at the end of the year of the performance of the individual executives and the Company, and occasionally
making mid-year determinations where the circumstances warrant an immediate reward, we can take all market factors into account and reward
our executive officers appropriately for their performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Equity-Based
Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee believes that equity-based participation provides our executive officers a strong economic interest in maximizing
stock price appreciation over the long term and aligns their interests with the interests of our stockholders. Equity-based awards are
made pursuant to the Company&#8217;s equity incentive plans. The ProPhase Labs, Inc. 2022 Equity Compensation Plan (the &#8220;2022 Plan&#8221;)
currently authorizes us to issue various equity-based awards to eligible employees, directors, consultants, advisors and other service
providers of the Company or any of our affiliates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2022 Plan has served as a key retention tool. Retention serves as a very important factor in our determination of the type of award to
grant and the number of underlying shares that are granted in connection with that award. In addition, our Compensation Committee considers
cost to the Company in determining the form of award, as well as our desire to have equity awards drive and reward performance over an
extended period of time in order to promote long-term value for our stockholders, and to be an integral part of a competitive compensation
program. Our Compensation Committee believes that stock options, restricted shares and stock grants are the best forms of award to achieve
these goals, as stock options are designed to deliver value to executives only if our stock price increases over the value at the time
of grant, and restricted shares and stock grants provide compensation that fluctuates with our stock price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the size of an option, restricted stock or stock grant to a named executive officer, both upon initial hire and on an ongoing
basis, our Compensation Committee considers competitive market factors, the size of the equity incentive plan pool, cost to the Company,
the level of equity held by the executive and by other officers, and individual contribution to corporate performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
there is no set target level for holding options or stock ownership, our Compensation Committee recognizes that the equity-based component
ensures additional focus by our executive officers on stock price performance, enhances executive retention, and aligns the interests
of our executive officers with the interests of our stockholders. Accordingly, the exercise price of stock options is tied to the fair
market value of our common stock on the date of grant. A grant of stock options typically will vest over a two to three year period (although
in some cases the vesting terms may be longer). However, the Compensation Committee may at times determine that a fully vested award
is appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no set formula for the granting of awards to individual executives or employees. The number of options awarded may vary up or down
from prior year awards, based on the Compensation Committee&#8217;s review and consideration of the above-listed goals and factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
keeping with our executive compensation program and philosophy for incentivizing the performance of our executive officers, as noted
above, our Compensation Committee has used grants of stock, including restricted stock. Such grants are intended to reinforce the alignment
of interests of our named executive officers with those of our stockholders, as the value of the awards granted thereunder is linked
to the value of our common stock, which, in turn, is indirectly attributable to the individual performance of our executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2024, the Compensation Committee decided to integrate an annual equity grant cadence for key employees, including executives officers,
which we believe aligns with market practice, aligns the interest of key employees with those of stockholders, reduces the impact of
stock price volatility and drives retention of our key employees through long-term vesting. These annual equity grants will be not include
bonus grants, if any, which will be evaluated separately. As part of this integration, in March 2024, the Compensation Committee granted
stock options to Mr. Karkus and other key employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Defined
Contribution Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
1999, we implemented a 401(k) defined contribution plan for our employees. The 401(k) plan is the Company&#8217;s primary retirement
benefit for its employees, including its executives. For executive officers, as well as all other employees, the Company makes a contribution
to the plan annually based on the amount of the employee&#8217;s 401(k) plan contributions and compensation. The contribution to the
plan by the Company consists of a 100% match of the employee&#8217;s contribution, up to 4% per person, per annum. The Company&#8217;s
total contribution to the 401(k) plan in 2023 for its named executive officers, in the aggregate, was approximately $17,880. Company
contributions to the Company&#8217;s 401(k) plan are included in the Summary Compensation Table as &#8220;Other Compensation.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not provide its executive officers with any type of defined benefit retirement benefit or the opportunity to defer compensation
pursuant to a non-qualified deferred compensation plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Perquisites
and Other Personal Benefits</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides executives with limited personal benefits. The Compensation Committee reviews annually the levels of personal benefits
provided to the executives. Medical and dental insurance is provided to each executive, along with all other eligible employees, subject
to the same terms and conditions, including premium payments that apply to all other eligible employees. Life and disability insurance
is provided to each executive at no cost to the executive. All such welfare benefits terminate at the time each executive is no longer
employed with the Company or as otherwise provided in the applicable employment agreement (except as otherwise required by continuation
coverage laws).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employment
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amended
and Restated CEO Employment Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2018, the Board approved the Amended and Restated 2015 Executive Employment Agreement with Mr. Karkus (the &#8220;CEO Employment
Agreement&#8221;), which became effective February 23, 2018 (the &#8220;Effective Date&#8221;), subject to stockholder approval, which
was subsequently attained at the Company&#8217;s 2018 Annual Meeting of Stockholders held on April 12, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the CEO Employment Agreement, Mr. Karkus&#8217; current base salary is $675,000 per annum. Mr. Karkus is eligible to receive a bonus
in the sole discretion of the Compensation Committee, and is also eligible to receive regular benefits routinely provided to senior executives
of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the CEO Employment Agreement, in the event of a termination of Mr. Karkus&#8217; employment by the Company for &#8220;Cause&#8221;
or due to his voluntary resignation without a &#8220;Good Reason&#8221; (as such terms are defined in the CEO Employment Agreement) (each
an &#8220;Ineligible Termination&#8221;), no severance benefits will become payable to Mr. Karkus. If, however, Mr. Karkus&#8217; employment
is terminated by the Company for any reason other than termination for Cause or due to his voluntary resignation without Good Reason,
then Mr. Karkus will be entitled to receive the benefits and payments set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the CEO Employment Agreement, Mr. Karkus is eligible to receive the following benefits and cash payments in the event of
a termination of employment other than an Ineligible Termination:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    cash severance payment equal to 2.5 times his then current base salary (<i>i.e.,</i> 250% of his then current base salary). Such
    cash severance payment will be paid as follows: (x) one-half of the cash severance payment will be paid in a lump sum within five
    business days following the effective date of the termination; and (y) the remaining one-half of the cash severance payment will
    be paid in 12 equal, consecutive, monthly installments commencing on the first business day of the month following the effective
    date of the termination; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    of his outstanding and unvested stock options and/or restricted stock will automatically vest concurrently upon such termination
    of employment, regardless of any prior existing vesting schedules.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Mr. Karkus&#8217;s employment terminates by reason of his death or disability, then the cash payments described above under will be paid
only to the extent of the proceeds payable to the Company through a &#8220;key man&#8221; life, disability or similar insurance relating
to the death or disability of Mr. Karkus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that Mr. Karkus has received a cash payment described above in connection with his termination of employment and it is determined
that his employment termination was in connection with a Change in Control (as defined in the CEO Employment Agreement), then Mr. Karkus
will be entitled to receive an additional payment as described below, less the amount of payments previously received in connection with
the termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event Mr. Karkus&#8217; employment terminates due to a reason other than an Ineligible Termination, death or disability, and if such
termination occurs within (i) 18 months following a Change in Control, or (ii) prior to a Change in Control but in contemplation of a
Change in Control and the Change in Control actually occurs, then, in lieu of the cash payments described above, he will instead receive
a one-time payment in cash equal to $2,500,000. In addition, in such event, all of Mr. Karkus&#8217; stock options and/or restricted
stock will automatically vest concurrently upon such termination of employment, regardless of any prior existing vesting schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
involuntary termination of Mr. Karkus&#8217; employment due to a reason other than an Ineligible Termination, death or disability within
180 days preceding a Change in Control will be deemed to have been a termination of employment in contemplation of a Change in Control.
In determining whether a termination of Mr. Karkus&#8217; employment occurring more than 180 days preceding a Change in Control (due
to a reason other than an Ineligible Termination, death or disability) constitutes a termination of employment in contemplation of a
Change in Control, the court or other tribunal making such determination will consider the totality of facts and circumstances surrounding
such termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, Mr. Karkus, and his eligible dependents, will be entitled to Company-paid COBRA continuation coverage premiums under the Company&#8217;s
welfare plans, for a period of up to 18 months. Notwithstanding the above, if a termination of employment occurs as a result of death
or disability, then any cash severance payment will only be made to the extent that the proceeds are payable to the Company through a
&#8220;key man&#8221; life, disability or similar insurance policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
Excise Tax Gross-Up</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CEO Employment Agreement does not provide for tax reimbursement payments or gross-ups related to any change in control. Under the terms
of his CEO Employment Agreement, if any payments payable or benefits provided to Mr. Karkus become subject to the excise tax imposed
by Section 4999 of the Internal Revenue Code or to any similar tax imposed by state or local law, then the aggregate amount of payments
payable to Mr. Karkus will be reduced to the aggregate amount of payments that could be made without incurring such excise tax, provided
that such reduction will only be imposed if the aggregate after-tax value of the payments retained by Mr. Karkus (after giving effect
to such reduction) is equal to or greater than the aggregate after-tax value (after giving effect to the excise tax) of the payments
without any such reduction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Clawback
Provision</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CEO Employment Agreement includes a clawback provision. In the event the following events occur:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    mandatory restatement of the Company&#8217;s financial results occurs while the Company remains publicly traded and is attributable
    to misconduct or wrongdoing by Mr. Karkus;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Karkus received a payment of a cash bonus or was issued any Company shares as a bonus within three years preceding the mandatory
    restatement; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    amount of such cash bonus or share grant was calculated and awarded pursuant to a specific financial formula, and the cash bonus
    or share grant would have been diminished based on the restated financial results had the financial formula been applied using the
    restated financial results;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">then
Mr. Karkus will be required to remit to the Company the amount by which the original cash bonus or share grant would have been diminished,
net of taxes originally paid. However, if the net effect of the restatement is effectively neutral to the Company over the applicable
time periods, then no clawback amount will be due from Mr. Karkus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Arrangement with Robert A. Morse</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Morse received an annual base salary of $220,000 in 2022 and from January 2023 through April 2023 for his role as Controller. He received
an annual base salary of $275,000 from April 2023 through December 2023 for his service as Chief Financial Officer. In 2023, he was also
eligible to receive a bonus and equity awards in the sole discretion of the Compensation Committee, as well as regular benefits routinely
provided to other senior executives of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Arrangement with Monica Brady</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
Brady received an annual base salary of $200,000 for 2023 and 2022. She was also eligible to receive a bonus and equity awards in the
sole discretion of the Compensation Committee, as well as regular benefits routinely provided to other senior executives of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
Agreement with Mr. White</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of his employment agreement with the Company, Mr. White received an annual base salary of $350,000 (subject to adjustment from
time to time). He was also be entitled to receive a minimum annual bonus for calendar year 2022 in a gross amount equal to $50,000, provided
that he was actively employed by the Company and in good standing, without having received from or tendered to the Company notice of
an anticipated termination (for any reason). Mr. White was also eligible to participate in all benefit plans of the Company that are
generally available to similarly-situated employees of the Company. His employment agreement contained customary non-competition, non-solicitation
and confidentiality clauses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Inducement
Award to Mr. White</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an inducement to his employment as Chief Financial Officer of the Company, Mr. White received a stock option (the &#8220;White Option
Award&#8221;) to purchase up to 400,000 shares of the Company&#8217;s common stock. The White Option Award was made in accordance with
the employment inducement award exemption provided by Nasdaq Rule 5635(c)(4) and was therefore not awarded under the Company&#8217;s
2022 Plan. The White Option Award, when granted, was scheduled to vest over a four year period, with 12.5% vesting every six months following
the date his employment commenced (which was May 9, 2022), and contingent upon the commencement of his employment and continued service
through each vesting date. The options had an exercise price of $6.74 per share, the closing price of the Company&#8217;s common stock
on May 9, 2022, with a term of seven years. The White Option Award was forfeited on October 4, 2022 in connection with Mr. White&#8217;s
resignation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>White
Separation Agreement and Release</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his resignation, on October 4, 2022, the Company entered into a Separation Agreement and Release with Mr. White, pursuant
to which he received a separation payment of $10,000. Under the terms of the agreement, Mr. White agreed to serve as a consultant to
the Company through December 31, 2023, for which he received $90,000. Pursuant to the terms of the Separation Agreement and Release,
Mr. White forfeited all rights to the White Option Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2023 Fiscal Year End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning outstanding equity awards held by each of our named executive officers for the last
completed fiscal year of December 31, 2023, as of December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Awards</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#) Exercisable</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options (#) Unexercisable</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Exercise Price ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Expiration Date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Ted Karkus</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">100,000</td><td style="width: 1%; text-align: left"><sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">400,000</td><td style="width: 1%; text-align: left"><sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">9.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/4/2030</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Robert Morse</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/20/2029</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: left"><sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40,000</td><td style="text-align: left"><sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/4/2030</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Monica Brady <sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 500,000 options was granted on April 4, 2023 was scheduled to vest in 5 equal annual installments beginning on April 4, 2023,
    subject to Mr. Karkus continued service through each vesting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 50,000 options was granted on October 9, 2022 was scheduled to vest in 4 equal annual installments beginning on October 9, 2022,
    subject to Mr. Morse continued service as an employee of the Company through each vesting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Award
    of 50,000 options was granted on April 4, 2023 was scheduled to vest in 5 equal annual installments beginning on April 4, 2023, subject
    to Mr. Mr. Morse continued service as an employee of the Company through each vesting date.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2023, Ms. Brady had no outstanding or exercisable options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
Versus Performance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table reports the compensation of our Principal Executive Officer (the &#8220;PEO&#8221;) and the average compensation of the
other named executive officers for the respective fiscal year (&#8220;Other NEOs&#8221;) as reported in the Summary Compensation Table
for the past three fiscal years as provided in this Amendment and the Company&#8217;s proxy statement as filed with the SEC on April
27, 2023, as well as their &#8220;compensation actually paid&#8221; as calculated pursuant to recently adopted SEC rules and certain
performance measures required by the rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO<sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CEO<sup>(3)(4)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>for Other NEOs<sup>(2)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid to</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs<sup>(3)(4)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Initial</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fixed $100 Investment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Based on:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder Return<sup>(5)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Income<br/> ($ in thousands)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-weight: bold; text-align: justify">2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">3,367,200</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">1,922,200</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">278,580</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">134,080</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">44.34</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right">(16,782</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">902,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">902,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,050,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">237,724</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">157.14</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,463</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">941,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">959,937</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">289,161</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78.28</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,273</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts reflect the Summary Compensation Table total compensation for Ted Karkus, our PEO for each of the years listed. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    2023, the amount reflects the Summary Compensation Table average compensation total for Robert Morse, our former Chief Financial
    Officer, and for Monica Brady, our former Chief Accounting Officer. For 2022, the amount reflects the Summary Compensation Table
    compensation total for Monica Brady, our former Chief Accounting Officer, and Bill White, our former Chief Financial Officer, who
    were the Other NEOs for 2022. For 2021, the amount reflects the Summary Compensation Table average compensation total for Monica
    Brady, our former Chief Accounting Officer (who also served as Chief Financial Officer during 2021), who was the Other NEO for 2021.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amounts shown for Compensation Actually Paid to our PEO and Average Compensation Actually Paid to the Other NEOs have been calculated
    in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually realized or received by such persons. These
    amounts reflect total compensation as set forth in the Summary Compensation Table above for each year, adjusted as described in footnote
    4 below.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
    Actually Paid reflects the exclusions and inclusions from the Summary Compensation Table total for our PEO and Other NEOs as set
    forth below. Amounts excluded, which are set forth in the Exclusion of Stock Awards columns in each of the PEO Compensation Actually
    Paid and the Other NEOs Compensation Actually Paid tables below in this footnote (4), are the aggregate of the amounts shown in the
    &#8220;Stock Awards&#8221; columns from the Summary Compensation Table. Amounts included, which are set forth in the Inclusion of
    Equity Award Adjustments column in each of such tables below in this footnote (4), are the aggregate of the following components:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Add
    the fair value as of the end of the year of all unvested stock awards granted in such year;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Add
    the change in fair value (if positive, or subtract if negative) as of the end of the covered year (from the end of the prior year)
    of stock awards granted in any prior year that remained outstanding and unvested at the end of the current year; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Add
    the change in fair value (if positive, or subtract if negative) as of the vesting date (from the end of the prior year) of stock
    awards granted in any prior year that vested during the covered year.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
values are calculated in accordance with FASB ASC Topic 718. The following types of equity award adjustments were not applicable to Company
equity awards, as such events did not occur: (i) adjustments for awards that are granted in the covered year and are outstanding and
unvested as of the end of the covered year, (ii) adjustments for awards that are granted and vest in the same covered year, (iii) adjustments
for awards granted in prior years that were forfeited or failed to meet the applicable vesting conditions during the covered year, and
(iv) adjustments for the dollar value of any dividends or other earnings paid on equity awards in the covered year prior to the vesting
date that are not otherwise included in the total compensation for the covered year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    column shows Total Shareholder Return (&#8220;TSR&#8221;) on a cumulative basis for each year of the three-year period from 202 through
    2023. Dollar values assume $100 was invested for the cumulative period from December 31, 2020 through December 31, 2023 in the Company.
    Historical performance is not necessarily indicative of future stock performance.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>PEO
Compensation Actually Paid</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exclusion</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inclusion</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)(a)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PEO</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; font-weight: bold; text-align: justify">2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">3,367,200</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2,465,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">1,020,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">1,922,200</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">902,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">902,200</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">941,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,537</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">959,937</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    components of the amounts shown in this column for our PEO are set forth in the table below:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value* of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior Years&#8217;<br/> Awards Unvested<br/> in Applicable Year<br/> (at Year-End)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in<br/> Value* of Prior<br/> Years&#8217; Awards<br/> that Vested in<br/> Applicable Year,<br/> at Vesting Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Award<br/> Adjustments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-weight: bold; text-align: justify">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">18,537</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">18,537</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*The
change in value for each award is measured from the value at the end of the prior year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Valuations: Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of date of grant. Adjustments
have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated
assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
NEOs Compensation Actually Paid</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Summary Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Table</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total for</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exclusion</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inclusion</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)(a)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Actually</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEOs</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; font-weight: bold; text-align: justify">2023</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">278,580</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">246,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">102,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">134,080</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,050,095</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">820,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,629</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">237,724</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">233,911</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">289,161</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    components of the amounts shown in this column for our Other NEOs are set forth in the table below:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value* of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Prior Years&#8217;<br/> Awards Unvested<br/> in Applicable Year<br/> (at Year-End)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change in<br/> Value* of Prior<br/> Years&#8217; Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>that Vested in<br/> Applicable Year,<br/> at Vesting Date</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Award</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjustments</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-weight: bold; text-align: justify">2022</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,813</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">4,816</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">7,629</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23,875</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,375</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,250</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*The
change in value for each award is measured from the value at the end of the prior year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Valuations: Stock option grant date fair values are calculated based on the Black-Scholes option pricing model as of date of grant. Adjustments
have been made using stock option fair values as of each measurement date using the stock price as of the measurement date and updated
assumptions (i.e., term, volatility, dividend yield, risk free rates) as of the measurement date.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
for Performance Relationship</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Item 402(v) of Regulation S-K, we are providing the following descriptions of the relationships between information presented
in the Pay Versus Performance table above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Actually Paid and Company TSR</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below shows the relationship between (1) compensation actually paid to our PEO and the average of the compensation actually paid
to our other NEOs and (2) our cumulative TSR, over the three fiscal years ending December 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form10-ka_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Actually Paid and Net Loss</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below shows the relationship between compensation actually paid to our PEO and the average of the compensation actually paid to
the Other NEOs and net loss attributable to the Company over the three fiscal years ending December 31, 2023, as reported in the Company
consolidated financial statements.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="form10-ka_002.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation for 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
setting director compensation, the Board considers the significant amount of time that directors expend in fulfilling their duties to
the Company. Only non-employee directors are entitled to compensation for Board service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period beginning July 1, 2022 and ending June 30, 2023 (the &#8220;2022 Director Period&#8221;), our non-employee directors were
entitled to receive, at their election, either:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    $35,000 annual cash service retainer (to be paid in quarterly installments beginning September 30, 2022); and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    stock option to purchase 40,000 shares of the Company&#8217;s common stock with an exercise price of $12.92 per share (the closing
    price of the Company&#8217;s common stock on the grant date); vesting in four equal quarterly installments of 10,000 shares over
    one year, with the first quarterly installment vesting on September 30, 2022 and each additional installment vesting quarterly thereafter,
    subject to the director&#8217;s continued service with the Company on each such vesting date. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the period beginning July 1, 2023 and ending June 30, 2024 (the &#8220;2023 Director Period&#8221;), our non-employee directors are entitled
to receive:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    $35,000 annual cash service retainer (to be paid in quarterly installments beginning September 30, 2023); and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    stock option to purchase 40,000 shares of the Company&#8217;s common stock with an exercise price of $7.31 per share (the closing
    price of the Company&#8217;s common stock on the grant date); vesting in four equal quarterly installments of 10,000 shares over
    one year, with the first quarterly installment vesting on September 30, 2023 and each additional installment vesting quarterly thereafter,
    subject to the director&#8217;s continued service with the Company on each such vesting date. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options granted under the director compensation program are granted under the Company&#8217;s Amended and Restated 2022 Directors&#8217;
Equity Compensation Plan (the &#8220;2022 Directors&#8217; Plan&#8221;) with an exercise price equal to the Fair Market Value (as such
term is defined in the 2022 Directors&#8217; Plan) of our common stock on the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
reimburse each non-employee member of our Board for out-of-pocket expenses incurred in connection with attending Board and committee
meetings. Non-employee directors do not participate in any nonqualified deferred compensation plan and we do not pay any life insurance
policies for the directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name <sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fees Earned or<br/> Paid in Cash <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards <sup>(2)<br/> </sup>($)</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <br/> ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left">Jason Barr</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">35,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">188,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">223,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Louis Gleckel, MD</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">223,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Warren Hirsch</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">188,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">223,000</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    employee directors do not receive director fees. Accordingly, Mr. Ted Karkus is not entitled to, and did not receive, any compensation
    for his service on the Board in 2023.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    each of the non-employee directors, this amount relates to a stock option to purchase 40,000 shares of the Company&#8217;s common
    stock granted to each of the non-employee directors on June 16, 2023 for the 2022 Director Period. The amounts reported represent
    the aggregate grant date fair value of the option awards granted to the non-employee directors in July 2023, determined in accordance
    with FASB ASC Topic 718. For a discussion of the assumptions and methodologies used to value the option award granted, see Note 7
    &#8220;Stockholders&#8217; Equity&#8221; to the financial statements included in our 2023 Annual Report.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2023, Mr. Barr held options to purchase an aggregate of 230,000 shares of common stock; Dr. Gleckel held options to purchase
an aggregate of 280,000 shares of common stock; and Mr. Hirsch held options to purchase an aggregate of 180,000 shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_004"></span>Item
    12.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Security
    Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Security
Ownership of Certain Beneficial Owners and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding ownership of our common stock as of April 19, 2024 by (a) each person known to the
Company to own more than 5% of the outstanding shares of our common stock, (b) each director of the Company, (c) the named executive
officers for the last completed fiscal year of December 31, 2023 and (d) all current directors and executive
officers as a group as of April 19, 2024. Unless otherwise indicated, the address of each person or entity listed below is the
Company&#8217;s principal executive office.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid">Name of Beneficial Owners</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock<br/> Beneficially<br/> Owned<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Percent of Class (%)<sup>(2)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Officers and Directors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted Karkus<sup>(3)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">3,215,329</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">16.7</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Monica Brady</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Morse<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason Barr<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">234,020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louis Gleckel, MD<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">373,840</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren Hirsch<sup>(7)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">170,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Current Directors and Executive Officers (5 persons)<sup>(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,135,689</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">20.6</td><td style="text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than 1%</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    ownership has been determined in accordance with Rule 13d-3 (&#8220;Rule 13d-3&#8221;) under the Exchange Act, and unless otherwise
    indicated, represents shares for which the beneficial owner has sole voting and investment power.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    percentage of class is calculated in accordance with Rule 13d-3 based on 19,078,529 shares outstanding on April 19, 2024. <span style="background-color: white">Shares
    of common stock that a person has the right to acquire within 60 calendar days of </span>April 19<span style="background-color: white">,
    2024 are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed
    outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership
    of all executive officers and directors as a group.</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    138,600 shares held by Mr. Karkus&#8217; son who resides with him and for which Mr. Karkus may be deemed the beneficial owner.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 35,000 shares that are vested or will vest within 60 days of April 19, 2024. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 220,000 shares that are vested or will vest within 60 days of April 19, 2024. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 270,000 shares that are vested or will vest within 60 days of April 19, 2024. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    options to purchase 170,000 shares that are vested or will vest within 60 days of April 19, 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    beneficial ownership of Ted Karkus, Jason Barr, Louis Gleckel, MD, Warren Hirsch, and Jed Latkin and options to purchase 673,100
    shares that are vested or will vest within 60 days of April 19, 2024. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below sets forth information with respect to shares of common stock that may be issued under our equity compensation plans issued
as of December 31, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Plan Category</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Securities<br/> to be Issued Upon<br/> Exercise of<br/> Outstanding<br/> Options, Warrants<br/> and Rights</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price of<br/> Outstanding<br/> Options, Warrants<br/> and Rights</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Securities<br/> Remaining Available<br/> for Future Issuance<br/> Under Equity<br/> Compensation Plans<br/> (Excluding<br/> Securities Reflected<br/> in Column (a))</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans approved by security holders<sup>(1)(2)(3)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">2,286,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7.59</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,093,285</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans not approved by security holders<sup>(4)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">665,126</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6.29</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">210,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023, there were 2,286,124 shares of our common stock issuable pursuant to stock options outstanding under the 2022
    Plan. At December 31, 2023, there were 1,093,285 shares of common stock that were available for issuance pursuant to the 2022 Plan.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023, there were 665,126 shares of our common stock issuable pursuant to stock options outstanding under the 2022 Directors&#8217;
    Plan. At December 31, 2023, there were 210,000 shares of common stock that were available for issuance pursuant to the 2022 Directors
    Plan.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    December 31, 2023, no stock options were outstanding under the 2018 Stock Incentive Plan. At December 31, 2023, there were no shares
    of common stock that were available for issuance pursuant to the 2018 Stock Incentive Plan.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Represents
    the number of shares of our common stock underlying stock option awards granted as inducements material to employees entering into
    employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and outstanding as of December 31, 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_005"></span>Item
    13.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
    Relationships and Related Transactions and Director Independence</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Certain
Relationships and Related Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of the charter of our Audit Committee, the Audit Committee must review and approve the terms and conditions
of all related party transactions. &#8220;Related party transactions,&#8221; as described in Item 404(a) of Regulation S-K promulgated
by the SEC generally refer to any transaction, arrangement or other relationship, or any series of similar transactions, arrangements
or relationships in which we were or are to be a participant, where the amount involved exceeds the lesser of (i) $120,000 and (ii) one
percent (1%) of the average of our total assets at year-end for the prior two fiscal years (which was approximately $89.8 million), and
in which any director, executive officer or holder of more than five percent (5%) of our voting securities (or affiliates or immediate
family members of such persons) had or will have a material interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
January 1, 2023, there have been no related party transactions except as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
Karkus, President of Nebula Genomics, a wholly-owned subsidiary of the Company, since January 2024, and prior to that Executive Vice
President and Co-Chief Operations Officer of ProPhase Diagnostics, Inc., a wholly-owned subsidiary of the Company, is the son of Ted
Karkus, our Chairman and Chief Executive Officer. For 2023, Mr. Jason Karkus received an annual base salary of $200,000, a bonus of $300,000
for his significant contributions related to the growth of ProPhase Diagnostics, Inc., a $7,800 vehicle allowance, and a $20,800 matching
contribution in the Company&#8217;s 401(k) defined contribution plan. He also received stock options with a value of $150,000 that vest
in four equal installments starting on the grant date. The compensation paid to Mr. Karkus was approved by the Company&#8217;s compensation
committee and audit committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Nasdaq listing standards, a majority of the members of our Board must qualify as &#8220;independent,&#8221; as affirmatively
determined by our Board. Our Board consults with our legal counsel to ensure that its determinations are consistent with all relevant
securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in the applicable
Nasdaq listing standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on these standards, upon the recommendation of our Nominating and Corporate Governance Committee, the Board has affirmatively determined
that each of our current non-employee directors is &#8220;independent,&#8221; as defined by the applicable listing standards of Nasdaq.
Thus, three of our four current directors are independent under the listing standards of Nasdaq. Mr. Karkus is not considered independent
because he is an employee of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_006"></span>Item
    14.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal
    Accountant Fees and Services</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table set forth below lists the fees billed to the Company by Morison Cogen LLP, the Company&#8217;s current principal accountant for
2023 and 2022 and Marcum LLP, the Company&#8217;s former principal accountant, for the first quarter of 2022, as described below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Description</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">271,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related fees<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,400</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,354</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">All other fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">346,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">126,354</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    fees consist of fees related to the audit of our annual financial statements and reviews of our quarterly financial statements. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related
    fees consist of fees related to comfort letter procedures and the provision of an audit opinion given in connection with our transition
    of auditors. For 2023, the $75,400 in fees billed were billed by Marcum who merged with Friedman LLP in September of 2022. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee reviews and pre-approves all audit and non-audit services to be provided by the independent auditor (other than with
respect to the <i>de minimis</i> exceptions permitted under applicable law). This duty may be delegated to one or more designated members
of the Audit Committee with any such pre-approval reported to the Audit Committee at its next regularly scheduled meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_007"></span>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_008"></span>Item
    15.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibits
    and Financial Statement Schedules</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)(1)
Financial Statements. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Index to Financial Statements, which appear on the Original 10-K. The consolidated financial statements listed in the accompanying Index
to Financial Statements are filed therewith in response to this Item.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)(2)
Financial Statement Schedules.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
schedules have been omitted because they are not required or because the required information is given in the consolidated financial
statements or Notes thereto set forth under Item 8 above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)(3)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&#8224;+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315217002984/ex2-2.htm" style="-sec-extract: exhibit">Manufacturing Agreement, dated March 29, 2017, by and between Meda Consumer Healthcare Inc., Pharmaloz Manufacturing, Inc. and Prophase Labs, Inc. (incorporated by reference to Exhibit 2.2 of the Current Report on Form 8-K (File No. 000-21617) filed on March 29, 2017).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000114420415038044/v413615_ex3-3.htm" style="-sec-extract: exhibit">Certificate of Incorporation of the Company, (incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K (File No. 000-21617) filed on June 19, 2015).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-bylaws2024.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of the Company (as of March 26, 2024) (incorporated by reference to Exhibit 3.2 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/literacompareredline-pro.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of the Company (as of March 26, 2024, marked to show changes) (incorporated by reference to Exhibit 3.2.1 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/0000921895-97-000237.txt" style="-sec-extract: exhibit">Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of Form 10-KSB/A (File No. 000-21617) filed on April 4, 1997).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315220004807/ex4-3.htm" style="-sec-extract: exhibit">Description of Common Stock (incorporated by reference to Exhibit 4.3 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 26, 2020).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000114420409044702/v158614_ex10-1.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement between the Company and each of its Officers and Directors, dated August 19, 2009 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on August 19, 2009).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315223021848/ex10-1.htm" style="-sec-extract: exhibit">Amended and Restated 2022 Equity Compensation Plan (incorporated by reference to Exhibit 10.1 of the Company&#8217;s Current Report on Form 8-K (File No. 000-21617) filed on June 20, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315223021848/ex10-2.htm" style="-sec-extract: exhibit">Amended and Restated 2022 Directors&#8217; Equity Compensation Plan (incorporated by reference to Exhibit 10.2 of the Company&#8217;s Current Report on Form 8-K (File No. 000-21617) filed on June 20, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-formof2022plannqo.htm" style="-sec-extract: exhibit">Form of Non-Qualified Stock Option Agreement pursuant to 2022 Equity Compensation Plan</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-formof2022planinc.htm" style="-sec-extract: exhibit">Form of Incentive Stock Option Agreement pursuant to 2022 Equity Compensation Plan</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-director2022plano.htm" style="-sec-extract: exhibit">Form of Option Agreement pursuant to 2022 Directors&#8217; Equity Compensation Plan</a> </span></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315218002422/ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated 2015 Executive Employment Agreement with Ted Karkus, effective February 23, 2018 (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K (File No. 000-21617) filed on April 16, 2018).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315221007538/ex10-18.htm" style="-sec-extract: exhibit">Lease agreement by and among ProPhase Diagnostics, Inc., BRG Office L.L.C. and Unit 2 Associates L.L.C. for the corporate headquarters and diagnostic lab facility located at 711 Stewart Avenue, Garden City, NY 11530 (incorporated by reference to Exhibit 10.18 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 31, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315221032692/ex10-1.htm" style="-sec-extract: exhibit">Sales Agreement, dated December 28, 2021, between ProPhase Labs, Inc. and ThinkEquity LLC (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on December 29, 2021).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315222016524/ex10-1.htm" style="-sec-extract: exhibit">Lease Agreement by and between ProPhase Diagnostics, Inc. and BRG Office L.L.C. and Unit 2 Associates L.L.C., as tenants in common, dated June 10, 2022 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on June 13, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315222016524/ex10-2.htm" style="-sec-extract: exhibit">Guaranty dated June 10, 2022 (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K (File No. 000-21617) filed on June 13, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315222016524/ex10-3.htm" style="-sec-extract: exhibit">First Amendment of Lease, dated June 10, 2022, by and between ProPhase Diagnostics, Inc. and BRG Office L.L.C. and Unit 2 Associates L.L.C., as tenants in common (incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K (File No. 000-21617) filed on June 13, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315222019965/ex10-1.htm" style="-sec-extract: exhibit">License Agreement by and between ProPhase BioPharma, Inc. and Global BioLife, Inc., dated July 19, 2022 (effective as of July 18, 2022) (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on July 21, 2022)</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315222035948/ex10-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement by and among Stella Diagnostics Inc., Stella DX, LLC and ProPhase Labs, Inc., dated December 15, 2022 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on December 20, 2022).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/ex10-1.htm" style="-sec-extract: exhibit">Unsecured Promissory Note and Guaranty issued to JXVII Trust, dated January 26, 2023 (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on January 30, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/ex10-2.htm" style="-sec-extract: exhibit">Common Stock Purchase Warrant issued to JXVII Trust, dated January 27, 2023 (incorporated by reference to Exhibit 10.2 of the Current Report on Form 8-K (File No. 000-21617) filed on January 30, 2023).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17*&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000149315223002940/ex10-2.htm" style="-sec-extract: exhibit">Latkin Offer Letter, dated as of December 28, 2023, by and between the Company and Jed A. Latkin (incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K (File No. 000-21617) filed on January 4, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-exhibit191.htm" style="-sec-extract: exhibit">Insider Trading Policy (incorporated by reference to Exhibit 19.1 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-exhibit211.htm" style="-sec-extract: exhibit">Subsidiaries of ProPhase Labs, Inc. (incorporated by reference to Exhibit 21.1 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#sj_001">Power of Attorney (included on signature page).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prph-exhibit231consent.htm" style="-sec-extract: exhibit">Consent of Morison Cogen LLP, Independent Registered Public Accounting Firm (incorporated by reference to Exhibit 23.1 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex31-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Principal Finance Officer and Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-exhibit3211.htm" style="-sec-extract: exhibit">Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.1 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-exhibit3221.htm" style="-sec-extract: exhibit">Certification of the Principal Finance Officer and Principal Accounting Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (incorporated by reference to Exhibit 32.2 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</a></span></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/868278/000086827824000004/prophase-exhibit971.htm" style="-sec-extract: exhibit">Compensation Recovery Policy (incorporated by reference to Exhibit 97.1 of the Annual Report on Form 10-K (File No. 000-21617) filed on March 29, 2024).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
    INS**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
    SCH**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
    CAL**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
    DEF**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
    LAB**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101
    PRE**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Indicates a management contract or compensatory plan or arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
Filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;
Confidential treatment granted as to portions of the exhibit. The Company agrees to furnish supplementally a copy of any omitted schedule
or exhibit to the Securities and Exchange Commission upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+
Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish supplementally
a copy of any omitted schedule or exhibit to the Securities and Exchange Commission upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    16</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
    10-K Summary</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"><a href="#toc_001" title="Table of Contents">Table of Contents</a></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="b_009"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
April 29, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">PROPHASE
    LABS, INC.</span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Ted Karkus</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
                                            Karkus, Chairman of the Board,</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Options: NewSection; Value: 28 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="sj_001"></span>POWER
OF ATTORNEY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ted Karkus. and Jed Latkin, jointly
and severally, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him
or her and in his or her name, place and stead, in any and all capacities, to sign this Amendment No. 1 on Form 10-K/A, and to file any
and all amendments to this report and to file the same, with all exhibits thereto, and other documents in connection therewith, with
the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each
and every act and thing requisite or necessary to be done in and about the premises hereby ratifying and confirming all that said attorneys-in-fact
and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant
and in the capacities and on the dates indicated:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Ted Karkus</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jed Latkin</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Operating Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jed
    Latkin</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jason Barr</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason
    Barr</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Louis Gleckel</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Louis
    Gleckel</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Warren Hirsch</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    29, 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warren
    Hirsch</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 30; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwkAMRU/QO4RZS20HXdidFhWxihQRt6ONMthOSmas7ZG8pWOLGAJJ+P/lCzESa1rpEhnOizyDI1Z1qRxCjjdkNFf0jnSzTcDPHO/aOlbG9ecPTMkz6JlpKOXFC7210RaLBKLJWM7GcuKXZDqD+U4EXz0lc9MFGqdVCcoUcGCqWaNT3A0fjqolQ1XXR52QrSaTQBxGg/wGGcUS9tSoF/HDQpalIhj1FYg107P2rmXr0HxJWJZY+Tg70P8OPgYPSos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>OFFICER&rsquo;S
CERTIFICATION PURSUANT TO</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RULE
13a-14(a)/15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Ted Karkus, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Annual Report on Form 10-K/A of ProPhase Labs, Inc.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this Annual Report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this Annual Report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
    in this Annual Report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rule 131-15(f) and 15d015(f) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such disclosure controls and procedures<I>, </I>or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this Annual Report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this Annual Report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
    evaluation; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 29, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ted Karkus</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ted
    Karkus</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board and Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>OFFICER&rsquo;S
CERTIFICATION PURSUANT TO</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RULE
13a-14(a)/15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jed Latkin, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
    have reviewed this Annual Report on Form 10-K/A of ProPhase Labs, Inc.;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this Annual Report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
    the period covered by this Annual Report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this Annual Report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
    in this Annual Report;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
    (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
    Act Rule 131-15(f) and 15d015(f) for the registrant and have:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such disclosure controls and procedures<I>, </I>or caused such disclosure controls and procedures to be designed under our supervision,
    to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this Annual Report is being prepared;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">designed
    such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
    supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluated
    the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this Annual Report our conclusions
    about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such
    evaluation; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclosed
    in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
    or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
    reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
    the equivalent functions):</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
    reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
    internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 29, 2024</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Jed Latkin</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-top: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jed
Latkin</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Chief Operating Officer</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Finance and Principal Accounting Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>form10-ka_001.jpg
<TEXT>
begin 644 form10-ka_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &+ E@# 2(  A$! Q$!_\0
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M2VO(!?O%YRVQ<>84SC<%ZXR#^1H F^S0?\\8_P#OD4?9H/\ GC'_ -\BI:*
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MDCUI[CPY);:98W.FW%C=6^UCDR(RA@/J4)Y'^K%=;X,T*?PUX2L-(N98Y9X
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MJET71C)K=@-7T.3;IS+&?+6$+& KG&2?W8.=I[COD #];^(VLZ>?&P@BLO\
MB326:6A>-C_K9 C%\-SUR,8_&H=4\;>.M#\,66KW]IH^_4;Z".T@0.2(WCD<
MJW/#?*@!R>IS2-\+=?N=&\4PWVM6=S?ZU]E<3^6R*'BD\QMP'0?PC'89P.E=
M/XL\%W/B#P[H6EV]W%&^FWD$[O(IPZHC(< =_FR/I0!4\*^*?$;^,[KPOXG@
MT_[6MI]LCEL=VP+E1M.X\_>_#!ZY!KOJY6/PK<I\3I?%'VB(VKZ=]E\G!WA]
MRG/IC"_K754 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA1M._;@D\CVS5FSUF:YO8XWLUCM9S(()A+N9BAP=RX^7/)')Z<X- &O1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !11619:K=7EW>E(+=K:W+((XY\W'F*2,,I 5=W49;T
M/?@ UZ*PIO$+PZ3#>/;V\3O.\+>?<[(HRI89:3:<9V\<=2!3?^$BN#&DRZ=B
M)(XGNB\VUHMY_A&WYL#DY*\8QSQ0!OT444 %%%% $5S_ ,>LW^X?Y447/_'K
M-_N'^5% !;?\>L/^X/Y5+45M_P >L/\ N#^52T %%%% !6$='U&6_EO);ZV$
M\<<D5I-';?.%;&#)\V&P>@&!W[X&[10!CV-GJFGPPVWG6LREV:280,F!@DD@
MR$LQ8@YZ8S[5%)H=Y<2275QJ$)O?W?E/%:E8TV,6&5+DMG)!^8<'C'6MVB@#
M ;P_=@&2+4D2YF61;F0VV5<.0?E7=\I&,#);WS4SZ=>R^4898;5K.7;:EXS*
M#'LVG> PSDY(P1T'O6S10!SZ^&Y(U$,5^!;R)&MRK0Y:0JQ)*MD!<YP>#[8J
MS9:--:WD;R7:R6\!D-O$(MK+O.3N;)W8&0.!UYS6O10 4UT#XR6&/[K$?RIU
M% $7D)_>D_[^-_C1Y"?WI/\ OXW^-2T4 1>0G]Z3_OXW^-'D)_>D_P"_C?XU
M+10!%Y"?WI/^_C?XT>0G]Z3_ +^-_C4M% $7D)_>D_[^-_C1Y"?WI/\ OXW^
M-2T4 1>0G]Z3_OXW^-'D)_>D_P"_C?XU+10!%Y"?WI/^_C?XT>0G]Z3_ +^-
M_C4M% $7D)_>D_[^-_C1Y"?WI/\ OXW^-2T4 1>0G]Z3_OXW^-'D)_>D_P"_
MC?XU+10!%Y"?WI/^_C?XT>0G]Z3_ +^-_C4M% $7D)_>D_[^-_C1Y"?WI/\
MOXW^-2T4 1>0G]Z3_OXW^-'D)_>D_P"_C?XU+10!%Y"?WI/^_C?XT>0G]Z3_
M +^-_C4M% $7D)_>D_[^-_C1Y"?WI/\ OXW^-2T4 1>0G]Z3_OXW^-'D)_>D
M_P"_C?XU+10!%Y"?WI/^_C?XT>0G]Z3_ +^-_C4M% $7D)_>D_[^-_C1Y"?W
MI/\ OXW^-2T4 1>0G]Z3_OXW^-'D)_>D_P"_C?XU+10!%Y"?WI/^_C?XT>0G
M]Z3_ +^-_C4M% $7D)_>D_[^-_C1Y"?WI/\ OXW^-2T4 1>0G]Z3_OXW^-'D
M)_>D_P"_C?XU+10!%Y"?WI/^_C?XT>0G]Z3_ +^-_C4M% $7D)_>D_[^-_C1
MY"?WI/\ OXW^-2T4 1>0G]Z3_OXW^-'D)_>D_P"_C?XU+10!%Y"?WI/^_C?X
MT>0G]Z3_ +^-_C4M% $7D)_>D_[^-_C1Y"?WI/\ OXW^-2T4 1>0G]Z3_OXW
M^-/5 @P"?Q8G^=.HH *Q8])OFU1KZXNK5I8D>.U=+8AMK8/[P[OF /88'?OQ
MM44 <\- O391PRWUG*\=P\RA[(F([R20R&3D@L<'(Q[TJ>&YHHU@34!]G>.-
M+A#!DOL)/R'=\@(.,8. !C!YKH** "BBB@ HHHH BN?^/6;_ '#_ "HHN?\
MCUF_W#_*B@ MO^/6'_<'\JEJ*V_X]8?]P?RJ6@ HHHH **** "BBB@ HHHH
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MW^%2T58R+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"CST_NR?\
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M '[;_"I:* (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO\*>KAQD
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MM1.G+VD=NJ_7U)>FIT5%5=/OX=2M%N(3P>&7NI]#5JNF+4E=%!1113 ****
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M*-W[@^HI_E/_ ,_$GY+_ (4>4_\ S\2?DO\ A2:35F!@:3>S:5>_V/?M\O\
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M1H BN?\ CUF_W#_*BBY_X]9O]P_RHH +;_CUA_W!_*I:BMO^/6'_ '!_*I:
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MJUL5!.UEVC.0",@L">>P!&_6;!H5E;S3RJ;@M+N W7#D1!NHCY^3/7Y<'],
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M8_,&47U/I[^F1ZB@"Y15$:SI;6;7@U*S-JK;#.)UV!O3=G&:N(Z2QK)&RNC
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M147VF#_GM'_WT*/M,'_/:/\ [Z% #;RTAOK5[>==R,/Q!]17":_+=:?X?O\
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MQ'Z')B_@7J<[1117L'F!1110![KH'_(N:7_UZ1?^@"M&L[0/^1<TO_KTB_\
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MRSX:@CQ)<@C!%HV1_P #2O4ZQQG\7Y(]#"_PPHHHKC.D**** "BBB@ HHHH
M*Y^?P_<ZA<SR:A=PM^ZD@@D@@V2;&Q]\DD'!Z  #OWP.@HH PO[#OO/^V_VA
M!_:/F!O,%J?*V[-NW9OSWSG=U]N*U+"T%A8PVP<R>6N"Y&"QZD^V3FK-% !7
MA?Q/T>X36?$.HV^F^+%66V!ENK6YC6S;;$!EDVEB@'WAG^]TKW2OF?XM21/X
M_P!4NEL[=8[.:"&X%Q<3YG9H#(/E5@%4A-HQCGGN< 'O_A'=_P (7H6YD=O[
M.M\LC;E)\M>0>X]ZV:S?#TJ3^&M*ECLOL*/9PLMIC'D H"$_X#T_"M*@"*Y_
MX]9O]P_RHHN?^/6;_</\J* "V_X]8?\ <'\JEJ*V_P"/6'_<'\JEH \[N?!O
MBW2-6U*;PCKUE:V.IW3WD\%Y;[VBE?&]D.#G.,X.!T]R>H\(^&X?"?AJVTB*
M9IS$6>29A@R.S%F..PR>!Z>M;E% !1110 454?5+"/4DTY[N$7DBEU@+C<0/
M;_/0^AIL6LZ7/#--#J5G)% ,RNDZE8_]X@\?C0!=HJF^KZ;';0W+ZC:+!,<1
M2M,H5SZ*<X/X5-=7=M8P&>[N(;>$$ R2N$4'ZF@":BJKZE81RP1O>VRR7 !A
M5I5!E'^R,\_A3HK^SFNY;6*[@DN8AF2%) 73ZCJ* +%%%% !1110 5XWXY_Y
M'*__ .V?_HM:]DKQOQS_ ,CE?_\ ;/\ ]%K7=@?XC]#DQ?P+U.=HHHKV#S H
MHHH ]UT#_D7-+_Z](O\ T 5HUG:!_P BYI?_ %Z1?^@"M&OFY_$SW(_"@HHH
MJ2@HHHH **** "BBB@ HHHH \\^*/_,*_P"VW_LE>>5Z'\4?^85_VV_]DKSR
MO=PG\%'D8G^*PHHHKI, KU3X:?\ (N7'_7VW_H"5Y77JGPT_Y%RX_P"OMO\
MT!*X\;_"^XZ<+_$.RHHHKQ3U0HHHH **** "BBB@ HHHH *Y[QS_ ,B;?_\
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M*-T__/./_OX?\*EHJ2B+=/\ \\X_^_A_PHW3_P#/./\ [^'_  J6B@"+=/\
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M1$ 9S[G]?KSWJW10!6N-/LKN%H;FSMYHG;>R21AE+>I!'7WJPJJB*B*%51@
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MHID,,5M"D,$211(,*B*%51Z #I3Z "BBB@ HHHH BN?^/6;_ '#_ "HHN?\
MCUF_W#_*B@ MO^/6'_<'\JEJ*V_X]8?]P?RJ6@ HHHH **** "BBB@ HHHH
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M"+Q?97$+2V]M=31QQ^;,\?ELL2[F4DMOP<;3]TGCIFI[GQ)#!<W<,=G//]D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"5\LR!=N_A<Y[XSC/.,UJ4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% $5S_ ,>LW^X?Y447/_'K-_N'^5% !;?\>L/^X/Y5+6$M]<HH59,*HP!M
M%+_:%U_SU_\ '1_A0!N45A_VA=?\]?\ QT?X4?VA=?\ /7_QT?X4 ;E%8?\
M:%U_SU_\='^%']H77_/7_P ='^% &Y16'_:%U_SU_P#'1_A1_:%U_P ]?_'1
M_A0!N45A_P!H77_/7_QT?X4?VA=?\]?_ !T?X4 ;E%8?]H77_/7_ ,='^%']
MH77_ #U_\='^% &Y16'_ &A=?\]?_'1_A1_:%U_SU_\ '1_A0!N45A_VA=?\
M]?\ QT?X4?VA=?\ /7_QT?X4 ;E%8?\ :%U_SU_\='^%']H77_/7_P ='^%
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# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>form10-ka_002.jpg
<TEXT>
begin 644 form10-ka_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &+ E@# 2(  A$! Q$!_\0
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M +Y%-^W6GVHVOVJ#[0.L7F#>/PZU/0!%]F@_YXQ_]\BC[-!_SQC_ .^14M%
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M]\BC[-!_SQC_ .^14M% $7V:#_GC'_WR*/LT'_/&/_OD5+10!%]F@_YXQ_\
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M6H^)=,BN;=8;)UDMOM+.DN"&'WR3NR-HYQ\QXYKS3X8ZL^C^-K">ZU*WN?\
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MHH BN?\ CUF_W#_*BBY_X]9O]P_RHH +;_CUA_W!_*I:BMO^/6'_ '!_*I:
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MC?XT>0G]Z3_OXW^-2T4 1>0G]Z3_ +^-_C1Y"?WI/^_C?XU+10!%Y"?WI/\
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M_P"/6;_</\J*+G_CUF_W#_*B@ MO^/6'_<'\JEJ*V_X]8?\ <'\JEH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHI#G!QC/;- "T5SFFR7+1WEO=ZE?6
MU^56683I'MA7H6B(7;M..Y;'<9SF!;K5KBU2,:A) R6\UPLPB0M,H?$98%<
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MTE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWX YSGM@UU']BZ>T4T4UI#/'-()'2:-67( 4<8Q@  #Z5,^G6,D\,[V=NTT
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M .)H_P"$Y\.?]!'_ ,@2?_$UK[&I_*_N,_:P[HW//3^[)_W[;_"CST_NR?\
M?MO\*P_^$Y\.?]!'_P @2?\ Q-'_  G/AS_H(_\ D"3_ .)H]C4_E?W![6'=
M&YYZ?W9/^_;?X4>>G]V3_OVW^%5],U6RUBV:XL)O.B5RA;8R_-@''('J*NUF
MTT[,M--71%YZ?W9/^_;?X4>>G]V3_OVW^%2T4AD7GI_=D_[]M_A1YZ?W9/\
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M@C(-<Q:D^']=:T8XLKLYC)Z*WI_3\JY9?NJG-T>_KT?Z$[,Z>BBBNHH****
M"BBB@ K.U_\ Y%S5/^O27_T UHUG:_\ \BYJG_7I+_Z :J'Q(F7PL\*HHHKZ
M0\,**** /5/AI_R+EQ_U]M_Z E=E7&_#3_D7+C_K[;_T!*[*O Q'\61[%#^&
M@HHHK V"BBB@ HHHH **** "BBB@!J1I&"$15!)8[1C)/4TZBB@!KQI(NV1%
M=<@X89''(IU%% !1110 4444 %%%% $5S_QZS?[A_E11<_\ 'K-_N'^5% !;
M?\>L/^X/Y5+45M_QZP_[@_E4M 'A_CG_ (I351%>>._%TMS=9G6VL<,8T+[0
M3EU4#<=H]^,=*]&^'5_'J7@BRN8K[4;U2TJ^=J(43DB1@0VTD<$8')XKE_BA
MHTM_JD<L.FZ7-YM@UM)/=ZH;5POF!QA>AVLJL#SSG(K;^$DUO/\ #G3WMK5;
M8"29702F0LXD8%BQZDGGCCGB@#MZ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "D)"@EB !R2>U9FI:]::>3'DS7'011\G/OZ5G"PU
M77"'U&0VMJ>1 G!/U_\ K_E6$JR3Y8*[_K=BOV)[SQ&IE^RZ7$;NX/&5'RC_
M !_E[TRW\/SWDPN=9G,S]H5/RK[?_JK9L["VL(O+MHE0=R.I^I[U8J51<]:K
MOY=/^#\Q6[C8XHX8UCB1411@*HP!3J**Z2@HHHH **** "BBB@ HHHH *S]9
MTU=3T]XA@2K\T;>C?_7K0HJ914HN+V8&1X?U(WUEY<V1<P'9(#U/H?\ /I6O
M7-:M&^C:M%J\"GR9#LN%'\_\]Q[UT<<B2QK)&P9& 92.X-8T9/6$MU^*Z,2[
M#J***Z!A1110 5G:_P#\BYJG_7I+_P"@&M&L[7_^1<U3_KTE_P#0#50^)$R^
M%GA5%%%?2'AA1110!ZI\-/\ D7+C_K[;_P! 2NRKC?AI_P BY<?]?;?^@)79
M5X&(_BR/8H?PT%%%%8&P4444 %%%% !2$X!."<=A2TC LC!6*DC 8=O>@#&T
M[5[R^T^>^%M:RQDCR([>YW,/59,@!2#R<9QR,$CELFO7#6=M+:6"322VGVN2
M-Y]@1,#@':=S<\< <<D46VD:@DEU>37=E_:$T8A$D=J0A52<%UWY9L>X Z#W
MC70+Y+.VB34X5EBMC:/(+4X>,XQ@%^&&.N2.>E %^[U*1(K3[% L\UWS&LDG
MEJ%V[B2<$CCV/)_&J"^))9(EFBL 8(UC:Z+38:(LV"%&T[]N"3R/;-3OIU[+
MY1AEAM6LY=MJ7C,H,>S:=X##.3DC!'0>]0+X;DC40Q7X%O(D:W*M#EI"K$DJ
MV0%SG!X/MB@"S9ZS-<WL<;V:QVLYD$$PEW,Q0X.Y<?+GDCD].<&FS:[)#>.&
MM%^PI-]G>X\WYP^W/W-O*YP,YSGMCFHQI%]9DRP7$<_D"4V<+1;=K.?XVW?,
M!D] ./4XI[Z%+-=OYEVILGF^T- (L-OVX^_N^[GG&,Y[XXH A7Q#=;5673D2
M:=(WM4%QD.';'SG;\A'!.-W7C-:FFWKWMN[30B&>*1HI(U?> P/9L#((P>@Z
MUEKX>NC$AEU)'N(%C2VD%M@($;/S+N^8GH<%?8"M73K-[*W=99A--+(TLCA-
MH+'T&3@ 8'4].IH MUQ7B7XDV_A>^NH+OPSXEG@M@&>]MK -;D$ Y$A8#C.#
M[@UVM?.'QAO9;CQZ\+:KJ-Q:6;Q[K>*S62&U8Q[\89MKL5#,<CH2,G&* /;O
M!WC"Q\;:,^J:?;7D$"RF+;=QJK$@ Y&UB".?7J#70US7@6UOK;PO;->:Q#JD
M4RK-:30V:6RK R*44(H ]3T'7':NEH BN?\ CUF_W#_*BBY_X]9O]P_RHH +
M;_CUA_W!_*I:BMO^/6'_ '!_*I: /%/'>A:]KGQ3CB.G>&[R,Z>WV**_W',:
MLI9F"L'WAB<?PXSWKOOAG&T7@'3@;^SO5.\K)9IMB4%V^11@=.G(SD'->9?$
M_P :Z8/$4][X:O-4B\0Z3$]I=7-O$/)6(/\ ,C[N>'] 1^A'I_PXT.\\/>![
M&PU&.-+W,DLVR0OEG<MDGUY&: .ENKJ&RMVGG8A%P/E4L22<  #DDGL*JKK5
MG]GM993+;M=,%CBGA9),Y P5(R.2!GIR.>11K0#:9)NLIKQ00S10/LDP#G*'
M(^88R,$'TK)E35QH]O%)97=Y+]J64 O"'CC216 <[E!; [9]SWH W+W4+?3X
MXWN/-Q(^Q%BA>5B<$_=0$] :AFUNP@FAAEED5Y0A ,+_ "[CA=YQ\F3P-V.:
MJ:A+'J,)4:9J%P;>? -M.L+!]O)#>8O W%3@]<\50_L_5Q ]K-;M/)=PP+)<
MB5=L;*<-NR03QR" <GTZT ;EOJ]C=7KV<,K-,N[K&P5MI ;:Q&UL$X."<4-K
M%BNH"Q,S"?=M_P!6VP-MW;=^-N[;SC.<5C0K=V!A>ZLI$@T[SW\U71O/W$[
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M>4__ #\2?DO^%9^O1N/#NIDSR'_1)>"%Y^0^U5#XD3+X6>'4445](>&%%%%
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M$R^%GA5%%%?2'AA1110!ZI\-/^1<N/\ K[;_ - 2NRKC?AI_R+EQ_P!?;?\
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MI'<4^N=T&>2PO9M%NFY0EH&/\0ZX_K^==%12J<\;]>OJ"=PK.U__ )%S5/\
MKTE_] -:-9VO_P#(N:I_UZ2_^@&MX?$A2^%GA5%%%?2'AA1110!ZI\-/^1<N
M/^OMO_0$KLJXWX:?\BY<?]?;?^@)795X&(_BR/8H?PT%%%%8&P4444 %%%%
M!1110 454L]4L-0EN(K.[AG>W;9*L;AMA]_\]B.QJW0 4444 %%%% !1110
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M/_OH4 2T5%]I@_Y[1_\ ?0H^TP?\]H_^^A0!+147VF#_ )[1_P#?0H^TP?\
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M*B^TP?\ /:/_ +Z%'VF#_GM'_P!]"L#8EHJ+[3!_SVC_ .^A1]I@_P">T?\
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M /KDY/ R>*MV&GBQ\UFN)KF:5@7FFV[C@8 ^4   >@]?6KE% !1110 4444
M<]XH\4?\(U]D_P!#^T_:-_\ RUV;=NWV.?O5SO\ PM'_ *@__DU_]A1\4?\
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M%9?AD6(\*:.-,,AT\6,/V8R_?,6P;-WOC&:U* (KG_CUF_W#_*BBY_X]9O\
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M4S.R^&G_ ",=Q_UZ-_Z&E>J5Y7\-/^1CN/\ KT;_ -#2O5*\7&_Q?N/5PO\
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MXR'^RMZJO^NQM;/]SV%>?5Z'\4?^85_VV_\ 9*\\KW<)_!1Y&)_BL****Z3
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M_P"/6'_<'\JEJ*V_X]8?]P?RJ6@ HHHH **** "BBB@ HHHH **** "BBB@
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MG[-!_P \8_\ OD4?9H/^>,?_ 'R*X/J_F>K_ &M_<_'_ (!\[5Z/\*?^8O\
M]L?_ &>O0OLT'_/&/_OD4?9H/^>,?_?(JH4>65[F&(S'VU-T^6U_,EHJ+[-!
M_P \8_\ OD4?9H/^>,?_ 'R*Z#RB6BHOLT'_ #QC_P"^11]F@_YXQ_\ ?(H
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M2".3<N[+'+$#&<X&<#UJ[;:7>I?7<UW>P7$5R"I46S*ZISM4-O(P,G^'GK0
M[3-5N+V?RKFS6W+PK<0[9O,W(3_%P-K#C(Y'/!-57\221!II;$"U=93;NLV7
MD*'&"N %SS@Y/OBGVVF:C8F.3[3%=3*D=LA,/EJD0.6+#<=S$=Q@9QP.:C?P
MW+*CP2WX-NHE^S*L.&C+G.6;)W8[<#WS0!)_;=]YQLCIT(U'S HC^U'RMNS=
MNW[,]B,;>OMS5@ZPS:/;WD=MNGG98T@9\ 2$X(+8/ .><'IP#5<Z)?&87O\
M:,/]HB3=YGV4^5MV%=NS?GOG.[.?;BE&DW?V1;))DC2V\N2"X=-S/*&+,S*"
M!M/3'!Y/M0!$WB"\*.D6FQO=PK*UQ$;G"J$./E;;\Q.01D#W(J:/7I)KJ,Q6
MBFQ>80"<RX?>5W#Y-OW<D#.<Y[8YJ)O#]V 9(M21+F99%N9#;95PY!^5=WRD
M8P,EO?-2Q:$\%TH2Z'V!)EG6W\KY]X4*!OW?=R,XQG/?'% &C878OK*.XV[&
M;(9,YVL#AAGV((JS5+2;:2UTV-)EVRLSRNN0=K.Q8CCTSBKM !1110!%<_\
M'K-_N'^5%%S_ ,>LW^X?Y44 %M_QZP_[@_E4M16W_'K#_N#^52T %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5SGC'6-;T323>:-IEM>")'EN7
MN;D1)#&B[B?4D_IWKHZY/QYX2U#QCI<&GVNN_P!F6XDWW"?9?.%P!@JK?,O
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MBN*U[X@?V)K5QIW]F>=Y.W]Y]HVYRH;IM/K4RDHJ[-:5&=67+!79VM%><?\
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M7B2$_.V=J$E<'/!!)((YSWXJ.31XCILEG#-.-S"19)IGG*NI!4Y=B< J.,T
M1+J;6XUJ:X+/%9RC8J@9V^4C8'U)/7UJI=>(+^R?R+C2XEG(5\I<.\2(=WS.
MPCRN"O/RD<CFM%]%L9+N:Y=)2\XQ*GGR>7)\NWF/=M/  Z=JB7P]IZ(54WBD
MD9<7TX<@= 7W[L#)P,XY/% %,:Y=74YM(TM;<R19BG-PQ\QBF[,.8]LJCV.<
M<D"MFPN?MNGVUUMV^=$LF/3(S5%O#UFJ'[.T\<BH5BWW$KQQG;@,(RVW(SZ5
MI00I;6\4$0Q'&@11Z # H DHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (KG_CUF_P!P_P J*+G_
M (]9O]P_RHH +;_CUA_W!_*I:PEOKE%"K)A5& -HI?[0NO\ GK_XZ/\ "@#<
MHK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\
MGK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\
MXZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W*
M*P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_Y
MZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O
M_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<
MHK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\
MGK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\
MXZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W*
M*P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_Y
MZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O
M_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<
MHK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\
MGK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\
MXZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W*
M*P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_Y
MZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O
M_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#<
MHK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\ XZ/\*/[0NO\
MGK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W**P_[0NO^>O\
MXZ/\*/[0NO\ GK_XZ/\ "@#<HK#_ +0NO^>O_CH_PH_M"Z_YZ_\ CH_PH W*
M*P_[0NO^>O\ XZ/\*/[0NO\ GK_XZ/\ "@#7N?\ CUF_W#_*BL=KZY=2K295
(A@C:** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>prph-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaSFmbP9z5Z8SekhvWBwbWkKfyMuRLu6uCbNrx5mgfMC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:PRPH="http://prophaselabs.com/20231231" elementFormDefault="qualified" targetNamespace="http://prophaselabs.com/20231231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://prophaselabs.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="prph-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="prph-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>prph-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>prph-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.22b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://prophaselabs.com/role/Cover" xlink:href="prph-20231231.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://prophaselabs.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140685499082416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K/A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">ProPhase
Labs, Inc.. (the &#8220;Company,&#8221; &#8220;ProPhase,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221;) is filing this
Amendment No. 1 on Form 10-K/A (this &#8220;Amendment&#8221;) to amend our Annual Report on Form 10-K for the year ended December 31,
2023, originally filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 29, 2024 (the &#8220;Original 10-K&#8221;),
to (i) include the information required by Items 10 through 14 of Part III of Form 10-K and (ii) amend Item 15 of Part IV of the Original
10-K to update the exhibit list. The information required by Items 10 through 14 of Part III of Form 10-K was previously omitted from
the Original 10-K in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to
be incorporated in the Form 10-K by reference from our definitive proxy statement if such statement is filed no later than 120 days after
our fiscal year-end. We are filing this Amendment to include Part III information in our Form 10-K because a definitive proxy statement
containing such information will not be filed by us within 120 days after the end of the fiscal year covered by the Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ProPhase
Labs, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000868278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">23-2577138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">711
    Stewart Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Garden
    City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">345-0919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.0005 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PRPH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,240,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,045,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Morison Cogen LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Blue Bell, Pennsylvania<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M\N]7R;]O3MF'_8<GU$M#*AE'/2F)>E90[?0U/=>]1:_QCFG5!-A2J[\=4)F
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( ,N#G5@'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ RX.=6"D:
MPJ;O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ RX.=6)E<G",0!@  G"<  !,              ( !S0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #+@YU8K'5F^PP*  !Q
M.@  &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ RX.=6++WPF_N @  B0X   T              ( !4!(
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #+@YU8EXJ[',     3 @  "P
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52P4&      D "0 ^ @  X1D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>40</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form10-ka.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://prophaselabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K/A" isDefinitelyFs="true" isOnlyDei="true" isUsgaap="true" original="form10-ka.htm">form10-ka.htm</File>
    <File>prph-20231231.xsd</File>
    <File>prph-20231231_lab.xml</File>
    <File>prph-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form10-ka_001.jpg</File>
    <File>form10-ka_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form10-ka.htm": {
   "nsprefix": "PRPH",
   "nsuri": "http://prophaselabs.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "form10-ka.htm"
     ]
    },
    "schema": {
     "local": [
      "prph-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "prph-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "prph-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 40,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 64,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 40
   },
   "report": {
    "R1": {
     "role": "http://prophaselabs.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-ka.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-ka.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14",
      "r16"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://prophaselabs.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-24-017001-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-017001-xbrl.zip
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M/ ,LO.:FXI9-FT,1Y.3DD!$O8&^B*D2I+-C LLF@_DF0$7N_9@.9WU0"K2=
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MUNM<"5 ?V!&4;Z(NU5A*<,RZ8MFKV2ON&<C]Y4D[E?B_S-QCCO@_+[+Y6[0
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M59(@SR@#&2HF*W?-H3#6U$4Q;\[3+ %7%]>*7ES.%)(9^X^2WJ?4 KS#Q+"
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M8$+@5%*76B<O*FYJ#U3XB%RC..Y&1W#YIL(&WP"M<Z 3'0@5&<MW&=9(698
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M0,!#H[Z[:,;948/Y'I -X.FF8:98ZY@@;C;K!4%G27Q_ +JQ;1$\1U;I[FF
M'\SAMK6-:OF7B65C:\%A2'>4Q%W2&.V'+*OYE,>PVIK,93:$N2>.33TN7TAK
MK49KDPQM\$-K_:FUG>?GSUSTBHIQW0F?;+&E@8GB3E08-X5V1ZFJZV.>&PG?
MX_SD;IPIZS(^RF9>SDI[([N4A.9NLELSQQ5'53*<XX*HT9<8/B[U,^W<%VF[
M\&:>FW$Z8.-6K/;>DSH=,<GU3W18XA#*T<B=)6;55-N=7UC',\I86QW@YPF
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M9@ZS>B)H5!'J)8&FG(D\$3#[C=;70_,]3."W\OS\4A'HD9#C2P\^*J96P%3
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M^ =;0U.8-:F7_A!?@L>LL0@2<DT]B6MF\=V5%F]4?!(SV=4 \,+AF+M1+#<
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MX$4RH3M7WRETYW6 XP^0L<]*T]/8:/CJ2$SH2\)UZVN2 A&;?) LX8'$AT6
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MWL'T%M7A#-E:@^4.YFP^</Z8:(S9P9#3Q(O&0Q_3SRFV7NO3^>)!Z2?3@)V
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MD'M8WPZAZ&2)3RWE/#%)+"9);- 8RW1*G>;*BKU1J61W;;).7\1R*#C)^"O
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M2R=.B)WH?Z&W=HR%N.LW #>.21?=OY9!(2<-$[(H%..0' ^+ 2V!+P,Z.^"
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MNT]6"(?H.RN8&C"Q+N1+GH<H,72GT>F4? 6F67_5"I: ISO]P#,_!E_F@\O
M3G5U[?/[9:-[YO+EFM ]9_#8FJB9P2_KQ*B=?O8WT'',TSXZ06@/%*^4DE<6
M#TRKBD%*70S"O;7BIRC/8YZ9FQW]$"52:6BR#ZY<53LD.#3@$_<!SKB@JEV#
M9_>;%7R/0PSEX2\S?2$Z14)ZX.]E;JE3,"0;-"%2, J"<^=DSDU"R5($!]S%
M<1BBC4V_HR=3!@["LC[B( SDB?QR?O6=SN<)BBXW:I^GIC7-6DB./)-LET%R
MN-/39"&#4:FAT1*991F'RVN+ D;/3$I,6N3A'QR;CZB@WOZ;FX#=8,PP%S=9
MTB36;'$?-D/X(P0['J^9Y)WZ/8;Q<QDX3V$*B1(*@YX<7KW3#J^.M&M_Y-A:
MV^A4-7AML.\])[3C,$0*Y S(#,PQRNR010._!];-#48HXY 3QY<P2;\D7P?9
M9=H7'Q;<)BI$)H&R'P-P,UD:SN<I")%)D.O. Q7 0*\;]_@J,3),K^J05X5=
MTGO(UPJK2;FK./_4,@[#"C!5#K8$'A?HV6L#YO8TF0W+BCV&SA/Y@9N8]4D]
MD,W\_**]ASL*CVOF32M3-^T\?E-D?R256^;S$VL\>M\-!.14MN28+=E> E8H
MW<SI_?N'[G]KM4:2"4<06J+8,*N3>8$B&#$XT(S9<8!S!9"<\SL/=#\"YF#1
M!>R_!<K\'?-8WR%US[_GDF=YU@V'Q^>9;#Y>('.&P"41''WA5$)DU9I?RD7I
M!#IY-R]Z+PJ+HI#'+B)6I4#37#>'+ J3,=TIGC2>6>3$:7Z6 :8J*_C4BL-1
MX+B:<2 :<KH/VHZURPWL$?P8KO[NX>!P;L159(DDXE[!IT,_($@+3VO^F!B_
M<00&'L_0IZ?EY.-U;:<KGI,XH>.> %QA[W*+V1J"DF#WP-@(= L&"' PLJZT
MZ5TKC,CG=!F'KTK0L+0\8X4#Z/9V-<MU-2HT\+*8'%2#.OTPV"]+P\C@*'?K
MJMI7SV5AR(%Z[[!@!K@!CB*RG<D*[_4"NJ _MK\X7@>=:BPAH#&J')/,";,;
MGKA%\$P/RQ;<E$2-D[C6JA@UEOUE!0@_\&( 8(DIQ5R(G/?"WN@1EWTZZ7E&
M,UVP^\ _P77W)NLB<FLBBC]>=V$;=\$"O"F=X:#G0FWGQ]TD*_[*/5KKY#X>
M>#]/U"MHW:0N<,EI@:<O7.D0T><3LX2<IV07?!CGO40!MJ@&>W&V3!)4YGQ<
M?YR/EYZ7GJQ5D&DUW32:>OT5@S'7OP:C56T_B_P?5Z$8\EAMFI3/O@</U-X%
M5N]AZ2*HI@K/\YH6J04N?3#)(^TS:'O&]4 C7P]L0]9\@2,\9VC1=99'+)>1
M,D5EQ$;-E;*166_H-;,H?&14IV9Z+T7'/\.&R.GR6MBKGZ[*(@YHK5:1M.MZ
MIU$<#IBR5PISRB^TWV2LP(I>>WNEK]UHU]0!LFJ'9)G*Y-!UB80C$1!\/Q80
M/$ZB;8G'NM,4(;Q0..2=E3)@0S? AFEUYI#WU=3:U:JM9ZN>Q=?8E3"1OT+B
M?ZJ<80B:0O;&CR5=Q+.!"DP%5. M$JC 4$ %"JA@D]6D*H519=53=*8)*XY[
ME&37!Q;"T($W,JMJDU=L7L; 14:]MU?7=D3Q9/I1 KN08D <W]MP3(.0']H1
MK[6.)S+,1$<FRYP4K(8R\XX9\KN!8W. HVZ:8R3JB7(XX9AVZQ/(D46S*!#R
MB&IT1OX="[:@+%L!U17NE92E4AX+<Y"V$4_3BL%O-F5JG5"#K;5C7N3VN$;H
M6EB%[7M83U)K=_2F>9!4SV0*:N""R;*3L;5,>]=WW+N^HGMQQ35>N\I'TEBR
M' 55 DW"0Z^."OGM?V)PA8EB6$.KAHMB7L\*M)[U0.4LXDU)RN:CB,.U4=41
M8N#T&,,JG^QB47F-XF#DATG%[2B.Q(2<L1W/%CJ)[V@MOLO+D!#(C18$;[(;
M1_1 ;%KA#^6[\NH'$W0<S?+CC]<U=F\SX%!ZU[#[HPPN7=Y-Y-O!LJ3)ZAX1
MALA4*27E2*F"WG2EH/1TX5X)S]X7_WV<\D83K@&->D=OI<7\U 30?:"^ %Z8
M(!M94(G<#1!2'*=[A5R2!\Z09#&UK=(?@K_R@*#%0IOE&5W*GBH27VR-G#9*
M**=YC3D".5R(+K==X#1'GX5@B$!&X?C$/S,6BS14IFRGC7_O2A0+]TIXA4+Q
MW\>3HFB:-26+2A;+_$IXK4CQW\?3LMA6LJADL=2OA!?P%/]]/"F+QB)E<?/?
MNQ+%PKT27LI4_/<Q)HJ3@189ETW[370M+1;6M:GJ45T;JRKD.;=/\.LS*_KN
M<.#G/'EOM>NZ4:MQK)KEG;\*\V35K?0<QZ8R#:5_FO9;K[AAOMBO9VV]\;Q$
M@W=.S^B+G\S"Y".Y<,D545PG#.-D+(,8D82-VE.8\*&XM,([PZ<ZSI<TBU+U
M9A<"')Y4PI$5L1L_2%K5QO:ZD/#27V(YDT% AC@LY(W8?/#B*>?^KR-0<O3Q
ML9P$XO=%PW::,Q4?\-.1'Z06EK31QX3U0NG7R=UY+1!\<7?W&UW!>GN'P(_6
M#9O8P@LQNDUMY,O9])(-+8=&?Q[>6HZ+.HA_@9FYDSB* \[$6'#!O_A*FIP?
MZ_R3J;-=W'OG^!Y-R^2%I,^&Q_;!9H17R[_!80>^&P\]1$XI $C[')C6<FN7
MVQ>P>"P$V. 7=:>48FW=#5Z;_;*UK7-6P>)6?SS3:+1&H\"_951\$ K8+DU@
M:4H<E!US=^T(";.0^W6ST](-LS'K=ZM%2'CS3/+;U68IL!UF37[0:P=U> /-
M%Z]A!9,39EH1JQ OK/![6L1FP X\>H _^JJ?AQCT& <\[TZ"+UJM)LCD5"O>
M#$-D7E)6LPU3(ORR':A.@[:48OD+Y +3R&U/?M$V+.<8YN.-EMR46GJDIT(1
MLV%=NZJO2_5U8>,_Q_?/P32GV?+:'?Y/8NL^@FE*06#BJ5$<8-B!QYDS8Q#&
MFSG25B\<2D!$8 2BJAU&3U"3V'Z/1K'I4DN&1B@JXHAPR!B%R5@$>OIT[BE/
MWA,I'D=*?KP/NZ[ZL!?:AVVJ/FS5AZT.OL(=?"7I79SKX!/NY-*.O>D!]L\X
M!X67L]A3,"$HI63S*WY4$5;A7DE96NMFJQ%O4@V0+,[2!4:'PX-KIQZ:2-C[
M.J<:\&0UQ^S^YN=I@5FD;#[3*3U0N%=2CM:]O."?Z/2_3&!)B'8:Z9$D]1^Q
M*T@YN _4P9^=)3@Q5\_",7*]V!8CY886>%=8!(J# L6<O5 CGPOOY'B13V3P
M[PCGA$K#,J-'\K :OEAAS_I'.W-" @(@Z(9FJ][<L7?A!?':T(QBFU$(MIII
M=HVIH&Y^;=A>8\&Y&#5/;%Z?8^GSQ)HY\\3J19TG)J93$34T% RMA8$S"L?&
MA%V#P(>6G<ZQ3,9XG@)#CQARM<W6/CEL)>)4IC7(MSO?FU43R I> 'SJ528/
M1SP[$?HLF>9KPZD>\0,>C_7#N.=$>+H.G2ABC,_#FOA0&P+Y6L!N': $F4.D
M[C,WQT]M'PY88I2*@,H)!!.-X)$/6I1AI:H<4GLY\Q)=3JF% [O'0CMPNARK
M";6FUJ@U<!P:/.B2W<2<>[6KO=\TH&P8NS@<M%?I/A")5\='V@WS6  T/0!1
M?71L?$(%RCQ0UZB@4PQ!Q*%GA!@49$1#QX_Q9R&\ &X:A0Z\*BL8ISQ[)]B,
M\9O00&&.3G(GO"2\*XYKH^)>B_;"P5%B7J3#E2S@.RTF.3O>K>_>TM@UF[$>
MQX1"]#G^4G><7>V-(?J_:9R: Y_X'JL(8"-MQ_AQ-YD_S$M@)3=$F/C%H<18
MJ ^^&0YJVV,"487 D0('_W7G9T>YA=J.6(\E*J?N';3U8+/?= ZJ'0VVR(75
M[U+?3B59/NZDA$W2IW&5<%O$Z$D@+QUHU\=KDL4T^6*0>@&5%Z8%H3NXLW W
MUZ'AU^A:#H>LAW]5N)!I0S(#^;N,D]EOX:XVL-+FH 'L$[R8Q(!UT&9E8;36
MR6Y*'3ZQH"L'YW)_LKS8"AZTB? $O5+"AO3\1Q251 H;4T+4S:+>?9'?/;43
M5F1SX06'B>+#VKZP+AP8V@?F^4/'1FV-2%)P-.QA<R(8W'$7+G:09R;G7H;(
M49KD*.P(Y*V(0BWZ/**5(M+_ 7JLDCX<+SWR]XX&#NMKYZ!I^*$@@>OQ<1>!
M?T&MB^\=Z\;S8:^0PE//KCZ'3CZBDD"R>)MELA.H)X\&EA,,+=XVR8F9 M'G
M(^O3 >*\/5- :8'*9@X>070/&@F/*(E::+F"FC=FC4X@)+KK>S'IUS=U_F$%
M3Y,!T!@"1SCP.(SP@?40@73%?$>D0(JXWTW@WX$Q\^3^O&GK'3CV;AF<+^#3
M6CB6%6TA_I8L)(LN $5N#^"LJ&2?BN=R9A>3P9Z-FK'S?1?$OT_XL6,_&5$8
M]",^*O33?9F(K:(A9FFWF&"G?3":_'@F;L'&4SP3^Z*-C8Z7$,YAET=-X)]!
M)! F^5[@=O5@>ZK:-1IT8^65ED.;EL$]2PYE46N9M\3L/2IV8O?1II$MF'RV
MZ;-,R^2]22>[,M/)5N^H()VPAV$E8(362C(H0I:N"%E2;!(CISH9F7_[5 LM
ME'K&0$4-\<Z'"[E'AKH":$?;1'A33L((4=9]0A.8FFUOP2:O9+"P@93DGE7M
M/+D]Z+@P=B.ANO 2E]V 8K+! PD9#^#"%=PB!Y<D"A.$;7&DH3^#=\'!R3*.
M*UQ"=@L*K)*QTBE"2\Z6:]WQ/X/$J0LS8[-Q.T@-DYN)._+(NAU/M(G!S_R0
MAG(GO<?<]QF-7#A[NBZKS'H?RL8KGBB]@]._5^&'(;[65';BD3@B02W">85(
MR))/D(6_^)P]!9KZD1^,?+# F/8!CL; HYC)1""$2\-@4H0R</(5$@":&BX3
M)6)*D>=[>S++D4$'=IX25FEGB*,ZY=)I]B1KEEBW6KD>H'D7#0*6>//]+#D9
M?.* !J#+9V<RO8\](&M2.+R#@^0;?DMAF>1^E2ZSK1C>S #;]-%$3'9AW$S=
M<%/B\8++ABJX7&C!95T57*J"RZ+9^\O6.BJ/N\X\;BLGC]LH:A[W(@![V!F)
M"3F'-EKR$0823IBPP.''MX[-PC5G:<OG4*YY02G(4NKA<+@E-.=X(+"/+[GK
MN&X:4I,%-8BN#_XF1O>._!OF:6=G%WI^D$A8DB/)2E2)(]@(GEO!:"&Q$A7K
MXC\^6X$=#V??$C&@<"I'SAWU).<$AC=W=F7>$F^O;V-$?KO!G-[3VQYQ:+>R
M8.2@3&P/(A!*YOIQ=N8&&&F1@;RX(!^%RE'72HB098.#S 36F$1.D;WG;2.O
M][Q@J" SB&^U7D7[ C$U%LTS>S+=E?*.N=*)U>VFWBC,Q/163:\WIY!KUHE'
M-/WL:^N>OZQE0P& H606!YC@!=2L ,J&)L2+#()Z*>L3E]?@ADP=!CE+K3=R
M3X#%;OP\A!AFZ^4J:O$0':HIN=Q-R65!XT!3A:BC<(+([J)#3G]/E.SPNA&1
MB1)%0GT'LVQ80!E&<"VO;^'I7JPM3G+<PM=W'W)_H8:@%(HMMJ;9KRS8 5F/
M8BYQM?TAA@WAS(HBBL;Y-NO%@8@+\[)O_]8)12X=B_ZX<(\<#S^[<6X95<_!
M,SQFIYCN5%*.Q;14KR%;@.G'?A!F2PSQ(6^X%X(WRL8KJ4)>_!N#E3RDB+,_
MARRXP0OP42>!PWI8TWAV=H%WN&*CB,E.1@Q+K&=T@TQPCC?WJ:#V/$'MR2X4
M>4CP@ENV)XH:0ZHKXAR)7V'=!?\K%!D-T5A!3-Q+*RNR-1"")[4=[D50GP'R
M565B./2OSML>TX; ]T,'_ SGK:@/IT*E$=:$1%$RER!;NF'=[6*YIA-JO3AZ
M2(?18EV5$$/?HTX0:G3H,:R-I6]$_5=%%$],[@JOK,*>%.I>2/;%PEJK$8AU
M>B1/_E14;GGP)D7!%1ZYH3T Z7?IR0S+0;:Z3J.IZC066J?14'4:JDZC,*?9
MX@'5IZH$VDF5P,7AY77E](]5%6@O?FVE?B\JHK'&4IE.3JE,LZBE,L?W Z?K
M"$@4M"A/DB#$E0Q":%?"2EIWN8P"-9A:PXZUNV/L5G+>&H6."M >D\5E+;<]
M?<48=1_=HX^1M^.Z[/4>C9@5R!ZV\\"!!<"%1FWO-]G&YI'!S/.@>8%"+&?B
M"  47[1M7DR$!>M$0F4&"53PWG>H]@E;?\EC@KN@:P</9=P] L\,==,JG1TE
MN[FR:^;*;JIQJX60X3*:5:MJ=G/=BHPBA)E&>U]$1V2#"$CC PDG-I,D[7%^
MD+T@_3P[,1*$-0DZ1C.51R6C/'SL_T$,"%(!B(*:%$OR8 VABG0TJ^O?KK3)
M=96GP1*$M;Y;D?92N37/-J*CS5?WMWYG0G#8HOR%&>62F348RU7Q+QI*4Y@$
M$W:>9TMQ9_@_:W=P%[EFLVI0BV;CEW\5S6,M4:HXB7$.HF@4_KR_?W=W5PV9
M7;WQ;_</ WL 9WJXSWHW5K /9[FUWVEUS'9GOU:K&8V#NM$TC7:M9AYT&OOL
MWMPSJX-HF.C>/;C1'M ?6#:LEG&5\</;SY87]^&CF#!&#V\"1A:!KG%C =.)
M \VD^>Y&6\?<$+K\71;=H<GRF?4L#+*&,?8I?&26&PUL-%DXXLC%P *3Q/7_
MIXT]A@.2T(TN G]$>"5G5E< E6@[CF?+YF/*1A$D&<7!P3 1RDXSJV;2,"LZ
M+RXIH8-.U F80EIG[S=MYP0<&S!MJAILTIYIM(SVKG!VX++QU>U6>9AXTX6U
M7C64D*Y%2(U&PZPUC&:MWJDU&ONW#:/>,IK_9??UO?H\PHIXE 0(%%%VXS21
M$U%Z, 9R-)\8U:OU5XO1I]ACFL&EJ+D]4F1NGQ2]G/=K_)]F _]=:^R/A.+?
MZSX@J@EBA<TC 0OTPA$ @S"Z$,V57.&>]HZ(F1 E;8=C8HO3HD5 >8W=N04L
M.:<.>9G?A'QAC.\9YQ0\.?6_K0V7L&T\J18G8ZX3,9 ?Y.( 84A<QV-[('CE
M$C0=@Q[?>9E../#O$*+7NV'A,P2P:B@1?-&[:VRC !;!5*P=F$;GH+EWT-Z#
M/\QZNQK=1T_)[-6(V4"11S5LB/=,,(M9HW$^B6EP>4E$X^K=_N$3XG$X"AQ7
M UDU#@ZVQI%J;*,)6 3I$-$.$T^Y3JV]S^X;\SE0F< <+P_+R,F\LE%?U%G"
MS[?:MDB+45.'R5KC#K6#6J/1KIG[MT:STS(:_V7WP*S&/')#G$T1AQX;<DQB
MDJ$D7IA$!+/F'%I\$OH/*ZD%=O+X")10AAH/XQM$[>1QA-K!G/*(7/7J ,;$
MH[=((LV?E$BN\P2KU\#.:W3VYQ?%7'>*$(6._XD1%_<H"WB-P_]>(DD30$2O
M"PV:-3Y;8(ODJJ[DJCAR-5<B;+9<3<[Y78"@F4K0%B1H#25HZPE0S(KG8Q6:
MWT?!P>$/WC]S11NE??G%]_9^)]AV!]B:^V7GHPE3,SOU]M&##X5@"YKA00J:
M2@J*+ 5P+#S/RY*SFQ<A 5LA "TE ,42 (FG+T7@6<? TPP_MTTVXPS(@QE*
M:FO':XX?;X!NJ0;HA39 -U4#M&J ?IYJW?@Z]&>3N_@J<SABVPLY8M=:1;Z^
MT@Q9G]NIU<R&:3XCWK?D0@PLV<N,-SRF631TYJ:G+W4$7L/%<DHBZ_<1QPBN
M/V'=(*9ACW4J_^N\) ;RXK ])9V-%G_RMM1DP-9UE+&[SN BG ;M9ET&[3OS
M2/$9PR)W*TV7\>R8-?2]FT>'=KZ[_"#R9MI9]:QZQ,OFOWI8 :\=AJ%O\]G-
MXDLY%" 106W K)X #.2)MU[R$,VUNEH?3DL736?7MTEDK4AK&P:XGNP.?J4=
MWC(O9KKVP8+#S]..X%)=^_*79AC->NT9J87.@M+F=3ZHV-BB&.>!$O?UBGO=
M;!T\Y\R^LK"S=ZJ9YCVS.>:>V>$\K"=I\T0%9/I@4%BO!X[W7?BV9V='JTR*
MI]0>;)W$&34E<NL4.;#G6DVS\0R1XP?LX>0!.R5?4T<L7?:\4Y:&ZX!;;6'G
M/.%Z8AF9E'+>#<,S<>8J!98_N,X?O$W"JLK*BB.L<^7:/X ]"L+S\#J)>;T#
MN;42H^J6BR,Q<Q4NG]"0-XK@T/$&G$\G7NZA,]6FO8+3;WZQ752_Z1:*;5V)
M[9K%]N"@U7R.50HRY<UEE[YS?(Z6D)'+#Z[?M5S\ZLSI,QD1D@+O/HB"93PS
MTX@L;Z'C7W>$B*S6"H4GFX9X\O;(9D/)YGIEL]X\>%XA=8@89Q<QW#[7=>2Q
MV:N(N:Z5/3B%&,HO_M0I,"/ 3":#.%.A'Z.Y>L<PC>34MN_,;"JY7&\A=LT\
M:-2>(9=?X<"T8X0T!'D:.F!^!@\$3LC/1.DZPA<Q;PK_].<?IZ?:=0#K3TY'
MR^-92=YC5U_I 2B>7=^^8FRCI82M,,(V5R1FK ,V.0N_60$*V9PRUGZNC"T@
M<+/%,M;^24#M*5DKEZR=6=%WQ\-("YAB9S1,3,H2=]HF\X/UJ4#.9'?M)^R;
MK6KBSFLXY!H<#V5;Q.] M; 7K,Y<2)=Q,)=M>>J%#J)97P<6UH1J%[[KV _S
M"L[!4G"$MD%P3$,)3C$%QS3FJVB)NR YCA4XC(ZJO'J5.7%;#25%+Y4B!<>U
M$"GZO_!O:J!X>^'?\0FHAU'D!Q[C)X$;]SB7\1F3<<"HB61KN$SA Q=&5X\&
MB9ZN&SC% XSU^=QZNI3 %/W "7W$A+MA-/Y7)Q0?.=GUDMW@W" *M\5=L(:T
M0]OV8P\GFVHG#JCC.=5Z7:GUE^*<PHGXTQ;VKTI!8?=U0X2&%TA_"GLHP-XN
M F!D9P2,F;:["$2JL?[2*S&BNUY+XE175M"U/!;NG=^[<$@<VA$?FUTSMZ3G
M!%C4W'H6-5?(HGS"5\J@/+THO\VH:,7!<W+P5F))%].J&?= ZW.ZH%/2@GP]
MKU(W.MK7ZA66MAGU9HU*V*R>/T*+)D]R#FJMIR5G7OSIY<!/;X5E9"J$W:(*
MK;D(H7W5,;=>F5[&5(<\F5X84DE;(94L%*FDI9!*%%+)\PX+A50R2>[BD4H.
MVHLQ]$L-5%(&$^*@/9\%D47TNF2V#XSX\+S$+;*$LL!?6'!D$!FG7ZZV,?ZS
M,%)//1R^1.3]^>[R3#OUPH@LW_>^'6/5^?:PTM711\5*"V2E:^O>]_SA Z@[
M,*!"5)-7]H -K2WDK:/#,\5;R^6M(\NU8Y<?QV>.][V+52#;QVGOCT\4IRV7
MT]ZSON,YV\YH9X?O%*,ME]'.K"YSMYG'+BZ/%8\ME\<N H85.5M\;C84B[VF
M5@#C'EQ8,>1YZM%H7\IWOK<B2Z/8Q0ZVC_2P>A$A6QW>+\*9DS-F3_#;;B[#
MR4S#PD*I2]^5O/AJ:8C_J7+J]6@N:ZA90(,'+Y8:T&VX$E^NY@>(KL+#7]@%
MBT#Z^"&UY_&+JV5=_$^5$PJM#5C D%O+NA#1C%<Y\KV^@R65CN5J4<"LB-[E
M#392\@ZOR-<PZ @'0#+X6D0YJ]IUMK$+D0CH\GX<>$XXT,)X-'+I=5NN"Q<
M5XP>\!YXN3]T(GQ""$Y_+W99!1A$W!?O0?E.;*@&2YIQ!-CC>SY"F^:?.B&=
M3_$(_B? )%986I[Z5P73S1;H/;D7?+UB-T)M8(&Z[&(CG=RT;*+X-&)#K54S
M=KJ[.^8N;N\ENY&N[M7>;\][2Y7'WY)6U+=4%O6\T"R'2M"M+D'W:_<M2AI1
MAH !W;=%,PN!0LP*<0HQ,W05#X$''R9I7;'A)#YTJ' ?WPR]F&P!R#J>O[AM
M_^)[;)5'S[+7DZ/]'J_0Z:@*G856Z+15A8ZJT"F:![ELK;.*I7 17?"1RV_F
M]$!"@"4/DI5<G7[X<GC]]?+X:NS\+=OR)*.M9@DK8K8+X3Y5A N#KHD3D ]$
M/JZLO37JZ.\8S9W>;E*#FWH[B:<C"G&-@WI#%_?#[D3"(AJ !]U#;$G;BD,$
M)1HX(7Q/93SP]"ZC=EW6J\#CT-?KLH'E]K$F"&\4PPX$_ *Z<\!B#WY%-[3B
M:. 'L*K>AEL?Y?'DWV,]U\\5/N!)UER5="T;7 /*[<QB)!@>B>7#PO'3?_]@
M/GM/EW+&98W>'K.Q>A&4Y,]<26&P'A3KY?G%Q\.K8YD"OM*UTR]'J7Z:X8@6
MX:4F;-@D4[.0R1I!8;WH!#;:2Z:P8)PCM%_BP))S6\QWM$BJWCW\_!A)3_O]
M:U%GSMO]<)]H36=#_KKO%%<S;3XC+92JTEA8P'ZTS'G_3XXQ/1I83C"TDK[$
M=[X5]/2LI4:;5\2PQ=' 87TB;[KO&9-'<CYZ9C'%"5FO,<1Z\(L8+A_^C(\1
M_FD:=^VHP.L" J\=%7C-#[Q*?E7!TV+JD])&%]/@J<2V$TNY./]V?%DY/]$.
MKZ_/+[\<_[7B"*1BMT<6]-N7\V^5P[,S[>+X\NK\RY7V[B_M^N/QU3%6Y%X=
M?[F^PF"E%6G,L@?:B 4(Y'8W\$.6P2:T1B-F!1CP=/T[K!T#TJ,X$E4D\*WO
M8#0VM=&K"70TQXW6M;_Q$BQ9@<]#!CH."U@(4 &#K'Z 15I:%,1\!(-KW?5C
M5[,$9F((^P,[8$?\>3<8^]7YS'BXS-5&$F0QC+N<-(P(X[4!RWZDT_#J@3.L
MB ?B)8Z7)<&#@T;'*CB;4Q)&S.KI>)$$Q ;"-=M"W8^191TCP[A3/%J<CD_#
M)D]CK/MS_U"G&V ]#Y92P@TK\H:6_%W(2W72P'/V%VA!AD0@K1U_F!0>4<0Y
M\ODC?/PK*<44,]0\3X3*(UD0Q^]3F:\R2.>%9@B508'MT')ZC[ZA[+NA3WD0
M/'K ]?1\^@P8KH_[@]Q'F\&H]U;>""M,;WC(/W0BJFB"1; P1&!P'I+O^1[C
MKP>>T/7CB'9I%# @&Q:#2\6F70N%#6^&U]E82!<,Z4\@D?@_?SF5+,,1[Q"G
MP".<(.4V(BS]"RX=6@^"B=T'7"N666)2(4LTD'7K!%',B$B_7]::N(W3F4^E
MG.;,+:4RC(DEJ@GDZ2&9,>J#<>C?(1=RO1NBNA!))?&8-#M5$;H*/TW5#Y=V
M_FF/RGP=4?#;^WF#WL@6)C@6%Y%+8]'F0D.]8!->21-A435V,^*SR1(6NX*G
M8UF+? N/.,*-QJ+?S#46VZBW,K=LF(O-),$;P 1SH;-HA8T**ZH45>M-)Y8X
M':8RH\_.<_ 4#=&23=.0;4U9D)P,B-KR5U!%15=$R%3AU28?DC*)* 6W6"^E
MF*RRDV"UYJ<B=XM&<#&WL>!E.=OX A159:=*F:)(:YKE4:;HPDINSD<,4Q8I
M++G:5V5O/G?9GX2]*:6S6"^EF*PR86_RZ0&(MZ'LS1(<EL58JJ)*455:$2J^
MO6EAB=([*PB4O?E*JJ9*N-4F*N-R7N,2Q9 (X:)8K)=23%915!7^^"O&4A55
MBJK2BE#A+<@S/W9"[8/+[._,54;D@HQ(3HO:265)/G/9)(Y$2"*2Q7HOQ>06
M157A3\)B+%51I:@JK0@5WIC\9@4!\[2/3A#: V5,*F.R(#NYI<8D%T>B1(ID
ML=Y+,;E%4?7ZDS !O,DT6R8ME.,HZH\BR-1K&029,RN,%&#, @!C#EX(&%,B
MK)3Q_MBQ38KDCMSW[G_13M_3/_Y;Z[S[+Y/SPT):&?V,?;H_^?OK\6]WWP\_
M7W[=__V\<?F?*[/V\<^>TSL9?+MW!K]?1JWS+Y^CP?G5T K;__G0&7T[/_MP
M^.G3OR[VW:/_'5]91C Z'GCGSO\>WI\:_S'^N;P_^OOOWO<O)_W:W][5_Z[M
M]Q<?S_>M<[?[X8#9%]>?O_^O]<D=_7;^Y\E1VS1JE];9N]_./GW[W/Y@Q[_]
M^9_W_[S_U]?&\9__J[GVP>>3#__T_CBR_:_VAZ-_OEE?KNN'M?[?__CN[\:?
M?UXVS=^#*^OZ]W?W'V[V[SY\L+]>'417_LG^Q_>_CRSW=/"W<?+7C5%K7YC!
M\,^@]O'^T[=/__GK7]<W[=I%Y_SBYJ^+*S_\-]^1_:[?>\#_#J*A^_;_ 5!+
M P04    " #+@YU8AJ"$'3E1  !+;   $0   &9O<FTQ,"UK85\P,#$N:G!G
M[+P%6)1-OS!^4P*"($BWA"!(=RZ"@("D2(<24M+2L81T@X"2BG1*=TLC'=+-
MTK!T[O[7Y[R/3_E>YWW><\[W_;_O^A;FNNZ=F7MF?ATS._!O\ 7@MIRTK#2
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MLSH[1K&T7 $HF\JI,A<E>C9^//>O>!=9;M&N::ZF I=S(CL,*4EAASYUU/Z
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MDBS%P+;6XRLF73D06(Y8B3=/PQ71YKTF?SI6+VER?^1N#,8CY1A#@_O1&/1
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M-/*J]$CUX6D3-E7-C;K-5:/]PAX/Q81V:K.@J<:4$P-&=!?/'H>-,/8MO6<
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MVA(%LLR32 [)5+B5S%_CPWD+5VP8IKIMD**FO]!.]=:O[+Y*^4:*XC.1/-Y
M #S50UEF" #5?@$S.Q(@$4>ES<7"8/QG0RN,IQEPH"D<QLOZ_ZK_7_7?K!X9
M0\9&!A,QGH_D?$ N,1JV25*SW K-5X^G=]G18PVR*O2[;*M; TY(*"^A%5*
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MK=@S?-C6%?7YG9)1E<<8SS%H_+IHXVM[_G=Q<T$HJ_KFP>Y1!M&.E;46JMU
M4B2G+(D)#?/N)M=<8!/9<2A5K,?4)P-=/>WR$KI.BXU7DE:OJ.<HYSG0/S?O
MS7MCOA@MMBZOJ*DJ"1I8$^)1U;62FNK+V)U2VH<#S@UJ5/0QFH8U 6U\K4PF
MU:8)EM+TV_GEN\TK!Z)E#P>/)3.2J'?D7]0Z17>5/:<DB6>2>9]L?(QJUR[/
M%^PL\J;AB(6BEVR65@>OZ07]*X;^O@@<Y]?+-[SYMGPF>(H# K\XG^K3U _U
MY]KZ"L;  67EH:)F0.WEN4 +*N#:Q3NO,3!/Q,;3FT8ZLW%ZN$[FU$:1;YOH
MH.3 \@KMT2[QJN0("J,9*:HR>JF+XGR;4R)-U7Y!O*KY4-=#2WD?COD6X33Z
M^ ZAY&7".EWG-AOLIH K4=OA :,'B7$C!GC91:R#0CG/0GT.%I %*"U+_I9I
M(8#.^1=;IA$L!VW,D=>';>R<,!6?4G049+[W_>RY&-RYORRZU7AF2BZU0"E
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MW9"*-YJO++A[Q1*RWY/,L9OVOEDPY53<0W673\#&<Z,--Q 4O(LY7) TOEZ
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MY[0^O%SB/,.2-MBL@M42%D-(UA".301*!QL=2?.>W$Z]_-0*'UI+]A2\A1E
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M?H)CYK?&8IGW[A(P-"_Y00K1M--/!W6Z%)[._YR)>[UQWX],[IO:_%U&5;*
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MKTH2U#*W>6A=_"Q@MD@6%RVF':!+2IZ-N;NMO%#X.Q(A /)@$&B#&@)$TD"
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M6P]N/[9Z:%-8A._WEKT5&2:$,6Z!J8/IP-3K*#.#94J^./UXVWJ3G?9W"54
M:N\BU,$S%#V9V?D_/^J Z_9AT'-S8,-BB<M*FYVSX-54")]-J6(G"M&FB\=>
M("VR;Q3VW9AL=P:AKHU^/L"+&F5>+7NKJQS-8(Q=F4 :1-L$<S3)#W@C/5\1
M8;;DY1%A'4Y)V)<O&1V?S Q>EBN1,B% J A NX!CFI3UEJ"J!0>9P"UX8I;*
MN#-3=I<7LL0ABUS;*;C!;8[["B0P)N7:VUMF=7.7>:XB2%Q5Q)C1P$X3Q#5U
M-ZTLE:HIULHPMKC9,N]_79/\7*W,5.L8L C#9R/KX$:=)038*FA<Q?:/.4Q-
M37(Q<+<6'3]\LN6G''/DCRR,I'#+](#[5MS2T>&M1=0TC<DJD4;HZV+THA5K
M."(B)/Y=:-\>3!B=R@U)9[.?\2& 42W'FRBLUU'OA&Q>VDT")W!(9!ZCK-PA
MWU@SDO'76@232[D\,1-D9_;0$[WWV,,3U\L!VV'M)4O-L/JR$9W\O/#Q$&?8
MMCP_*;YO;3&)QCX&X3<H(Z,VMN2>M5IK_E(IQE22U/1Y>1PBBOW^]X1OZ>'$
M@QDYA1@ES0WAG1$" "DQL;/WH/4R\/E0^NXC\* 9!-A/A<(=!>_/F)>[%+<G
M]-<O*(ZG0-<;WP&FGOFK.T\)"."-(C**=',6<7?U&V*:TH< 2<,08/Y)1%DS
M!!!.AP -OZ'4_RM?';/$A!0'WUC155,NZ$?V_/16X,X9_*)1YGF+X.LF&H.)
MZ_P9J#'Y^>!::IPPDAY[7K 5ZX XQA/>RUO,<H?!<Q7^*V$(('&%?>(J\.4/
M<=*O@[^3:[H]<;\RR/G1P] 8<WK@T=UB09>7).U!:>L_CYJJM;JG1[16PJR(
M@2P-_9O L&H&/Q@NA,.ZT2!OQUS\CN!_[X3B)ZU-W^*"0WY*1>)W"7YWX7[(
M1>''ZU*0S7]/M^2HQ+[CB'R\\3@S!<-4/.'*+*-BU(9DQRXMCU-/0Z#,"AF=
MB$CFHE-A-)79,E-[E^0-2[@D(6[9'W<NZHHMZZ&Z@>0GN)'J#A.)C6=7^SAG
MGJZ+:_ \&[Z/Z% ;6Y-XLJE;U4/T/.FU_D0@3SA2J',R^H5MJPA<^/0+-P42
M'7\IN@\9H;SHT5J)=X;Y@.?#US56'F2Q#5'VN%?>=0SPF+AI8O3!N%ZMA8!J
M@ ,YS$']8!#S?A($D!NV*K191]M.)WJ& %SZ:&#V3+*<BY(Q%:;<*_@!LT-^
MV,(4V-]1=MKOMC %\_[%ILU9PEQ /LFVJCJ@OO/Y?3I37O":&%R!Z#?'W8G*
ME!N.T8\O#O"3<72U9MT_2[5J\6R\$RRU4MK@C"BP#+S(YSZ-CRB;KL?<Y26N
M/#/L.*M(T*^+?+KF?91G1R!DA';:W8S7>. I,>%4B$&Q2Y09WJ+J4EE<4WI$
MYQ=2_+*U2%CTI/,YL+^_FUE;9I92&S=BD\.ECYTU0W[O%#%;>O$T>D30:<R6
MJFW.*YKR35F)#1I1R6L["5'@+#^8'H[5FG5I)S[ISBPSW/KL2!3'R;+2'(GQ
M\2#-BK.0$Q[!#;7+%T/U/=;H^V]*6LB>#Q:M$-#@)";9B7NN59BEH!FFEB%J
ML+ ]/+:GK-!X_GZW-[&4?CIFAS!9%B9'-@!N[L/<TN*2N=!X!:U7^L/9VN+0
MD]U$TT23<OH4M#=>PK9D94/2CLYV)4]8OF8ZSY(:IB@"5RLK!QQNN2[$;L7'
M&@4/JQ-4$=8^VBS[^8K( X 'IIYF]>_[-!SGZ \E;JCUC"# TVNY*2A:[M7Y
MZ+)[QG_]=0 "M$ G<3;H3@9\ANNE  '>J]U"!VV2:9#I:^OBYD#"N[BL3YIE
MRSPQPIAW^!&WCR' D24$*$K_^W\*A=)J1'(DBB/&+<[_V*SP:6&2Y8;%0OM(
M@*!#>BFZHE(C)U0QJV2+_N2TU(VV^S"-G\QCSTYIZE[:291:N$O:OU-TIQ:6
MRK.]D/6"*N%CBAL_"@B HQ/5//9..48SL:3]"<OG"*.T.ML[G&0LJ)_Q/0TK
M\2,-^P;JJ7S/PT++DD5#NE(-P?CB9%*WF!TYTN'#_#Q+):WYV<MAEEH^/1:"
MM9ET(9@MR\8"S;)9?H=2#T>E" XHH:5</T%6>JYY=\[FD:@=Q;YX9ZE+[IAR
M#Z-4^TY3Q\%9VH1JF*5]E+.5"Y]-AA/2E4K8W\?332SE&^)SQ/*F"]0>L.*Z
MDC>N-S ]U?A =U"1SO6"B+Q'55$P+# =_6'FSFJ-Y5H-!T7+\&(9U//76$+X
MA>?/^P>+IHM(?5$B'$S1^E@,5Q6Q^5>[G%4]=MNNC*Y>1VD22G^9SN!%F':\
M7TMS:9=?%;K,-R!HU)^YS9*C-ZNUU/T,8T-5L/X8/4^-A7RXC-0T9U>4^$15
M[*Z4.W/F+5Y"KZT--2_V!Y=W&/9'!1@[&'+4TP]S&]_2O.$:^>9GL<U0Z?R1
M[<'34+PFU"0[!^]#49(35>>X="[_7;;\D3E+;0+U3 X&Q6IXLB_>XNQ3V6S_
M8@\SL$%?X%WWV$UAA(6'MS; V/)-V #>$U*O_,HU.LI0OSTQ"PT+9'?FKMQ*
M?0E=GR.!%=Y*P:!%40*F)A]J]98&UD.N<U5BER^LU)6!)#FGW)76M%,<N'@O
M>8W\+\A$^;<LYW.;O5SN,/1(+@)UG@B;>&8<+4?W3*8S,8=937Y0J7&W/X[I
M6!+>@)LJ(Z2K.-C[@- _,CLC9HXM[9!?]:(98,7T2G+<U\2+7XQZ*<20'O:H
MR^G0$',RM-&KO<AJ=C\4JK=_"1IVB+ U.V.&E-4_E_9<SJ(-::$M;0CO'U>\
MI.ZCC.;Q.UHF:][6#5@@7 UIKF#B;DB%^[1NDNI\]K9(/5+Z,%*"VJ^#*?0P
MX-5%<KNIRO#)-!O.TXR.*^>Y#T[MV$0EI#78/*4P1Y'\A'"%LA&+7%($K=9L
MO?72V?-]SNQ[TX0<[$<=>SYZM8.9@$O9/_G.T'V]G>(R #QM>QM==U2/N11Q
MT]*X6WG7K>NNNX=S07_$#FHW@'K^4KYJ0U^/^[W1=4U .S<#-Q134,6I:ZW[
MQRS782,IU(M8!4.=*PAPHCDAJ$,0#EYQ:(0 %> K%LM/A:GI-WQ7U.VYAXWR
M:<%,2IPEW]--U&2=MQZ\=X&Q6[&K8'30BN'WV((X5,%&ZA7KM&T/?9:_MD
M-&@'RP)/_B[[>6\]4/ ].9&:DTVFNJ<:^;'4YTV/@1"'2=AQ$[\(^Z)$L-Y
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M]T@["'1O^!EMDWZ$@G;AEN6[TH^2"1[E*IPVVG=0HK$<#Z\(TA1G%P CE!=
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MG>O9L 2EOH"1M$DOY_%;#3_9;O>1*?&,39B.SF-_V10CM7&JCGS25U4>O\_
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M[85TKQ(T?%3 R*>1YHO?GP?YGT4N'O/HGPDW715>,?(U_;-*G"FM''QXRK<
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M<M\R#\:YHKV#"N5'@>-'">R?Y_PH.ZS8G4TE[TZ4WS"3/1[PX@TZ_.IK^=J
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MTQ\R;4>VE8$H#T>&4==H]Z1RQT8",K^D4KHL=/D1$UCV]L:-D(6.A:*/-MP
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MF&?:TS;+.P@"(L!T!6V15PA1H?12_Y\Q?>2[ISQZO>4L(D3.LLKJUJKO_MO
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MY5Y(;H_\#U!+ 0(4 Q0    ( ,N#G5B2.^--?P@  ,%(   *
M  "  0    !E>#,Q+3$N:'1M4$L! A0#%     @ RX.=6'- W0YU"   8$@
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M,C,Q+GAS9%!+ 0(4 Q0    ( ,N#G5CVGIBXNPL  ..0   5
M  "  05E 0!P<G!H+3(P,C,Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #+@YU8
M*) \.L$'  #B7@  %0              @ 'S< $ <')P:"TR,#(S,3(S,5]P
<<F4N>&UL4$L%!@     (  @ [@$  .=X 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>form10-ka_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="prph-20231231.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-03-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000868278</identifier>
        </entity>
        <period>
            <instant>2024-03-15</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003">true</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-12-31" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000005">0000868278</dei:EntityCentralIndexKey>
    <dei:AuditorFirmId contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0043">536</dei:AuditorFirmId>
    <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="Fact000010">10-K/A</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2023-01-01to2023-12-31" id="Fact000011">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000012">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000013">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-12-31" id="Fact000014">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2023-01-01to2023-12-31" id="Fact000015">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2023-01-01to2023-12-31" id="Fact000016">000-21617</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000017">ProPhase Labs, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-12-31" id="Fact000018">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-01-01to2023-12-31" id="Fact000019">23-2577138</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-12-31" id="Fact000020">711     Stewart Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-12-31" id="Fact000021">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-12-31" id="Fact000022">Garden     City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-01-01to2023-12-31" id="Fact000023">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-12-31" id="Fact000024">11530</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-01-01to2023-12-31" id="Fact000025">(215)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-01-01to2023-12-31" id="Fact000026">345-0919</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2023-01-01to2023-12-31" id="Fact000027">Common     Stock, $0.0005 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-01-01to2023-12-31" id="Fact000028">PRPH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-01-01to2023-12-31" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-01-01to2023-12-31" id="Fact000030">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2023-01-01to2023-12-31" id="Fact000031">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-12-31" id="Fact000032">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-12-31" id="Fact000033">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2023-01-01to2023-12-31" id="Fact000034">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2023-01-01to2023-12-31" id="Fact000035">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-12-31" id="Fact000036">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2023-01-01to2023-12-31" id="Fact000037">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-01-01to2023-12-31" id="Fact000038">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2023-01-01to2023-12-31" id="Fact000039">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2023-06-30"
      decimals="0"
      id="Fact000040"
      unitRef="USD">100240301</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2024-03-15"
      decimals="INF"
      id="Fact000041"
      unitRef="Shares">18045209</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000042">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorName contextRef="From2023-01-01to2023-12-31" id="Fact000044">Morison Cogen LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2023-01-01to2023-12-31" id="Fact000045">Blue Bell, Pennsylvania</dei:AuditorLocation>
    <dei:AmendmentDescription contextRef="From2023-01-01to2023-12-31" id="Fact000046">ProPhase
Labs, Inc.. (the &#x201c;Company,&#x201d; &#x201c;ProPhase,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; or &#x201c;our&#x201d;) is filing this
Amendment No. 1 on Form 10-K/A (this &#x201c;Amendment&#x201d;) to amend our Annual Report on Form 10-K for the year ended December 31,
2023, originally filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on March 29, 2024 (the &#x201c;Original 10-K&#x201d;),
to (i) include the information required by Items 10 through 14 of Part III of Form 10-K and (ii) amend Item 15 of Part IV of the Original
10-K to update the exhibit list. The information required by Items 10 through 14 of Part III of Form 10-K was previously omitted from
the Original 10-K in reliance on General Instruction G(3) to Form 10-K, which permits the information in the above referenced items to
be incorporated in the Form 10-K by reference from our definitive proxy statement if such statement is filed no later than 120 days after
our fiscal year-end. We are filing this Amendment to include Part III information in our Form 10-K because a definitive proxy statement
containing such information will not be filed by us within 120 days after the end of the fiscal year covered by the Form 10-K.</dei:AmendmentDescription>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
